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P O L IT IC S AND MEDICINE IN THE ESTROGEN REPLACEMENT CONTROVERSY:
A COMPARATIVE ANALYSIS OF THE UNITED STATES AND GREAT B R IT A IN

Frances B. McCrea, M.A.
Western Michigan University, 1981

This thesis investigated social and medical aspects of the Estro
gen Replacement Controversy (ERT) in the United States and Great
Britain.

American researchers claim that ERT, a treatment for meno

pausal and postmenopausal problems, substantially increases the risk
of endometrial cancer; British researchers minimize the risk and
instead emphasize benefits of the treatment.

Whereas British medical

practitioners are reluctant to prescribe ERT, their American counter
parts widely prescribe the treatment.

American feminists and con

sumer groups strongly oppose ERT; similar groups in Britain demand
the treatment. Whereas the British government has not regulated the
drug, in America, increasing restrictions have been placed on ERT.
To shed light on the interaction between epistemological and ideo
logical factors, the social forces which shape the controversy,
varying independently cross-culturally, were explored and elucidated.
This controversy is of interest since it demonstrates how two coun
tries, reach contradictory conclusions to the same problem based on
the same scientific data.
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CHAPTER I

INTRODUCTION

Estrogen Replacement Therapy (ERT), a treatment for meno
pausal and post-menopausal problems, is widely prescribed in the
United States and Western Europe.

By the mid 1970s, menopausal es

trogens had become the fifth most frequently prescribed drug in the
United States; in the early 1980s, menopausal estrogens were in the
fastest growing segment of the British pharmaceutical industry.
In the past few years, however, a major controversy has devel
oped around the risks and benefits of ERT.

Controversies in

Therapeutics, a book devoted to current medical disputes, designates
estrogen therapy as one of "society’s most pressing therapeutic ques
tions" (Lasagna, 1980).

Some scientists claim that ERT effectively

treats and even prevents conditions ranging from hot flashes to
osteoporosis (a bone disease which, in the United States, purportedly
afflicts 15 million persons, and is a cause of death for nearly
20,000 persons per year).

Some scientists make strong non-medical

claims for the benefits of ERT, maintaining that the therapy will
keep women "feminine forever".
Other scientists dispute these claims, and moreover argue that
ERT significantly increases the risk of endometrial cancer, gall
bladder and cardio-vascular disease, and may even increase the risk
of breast cancer.

Some researchers now warn that the estrogen-in

duced endometrial cancer risk exceeds the combined risk of breast,
lung, ovary and colon cancer.
Whether ERT heightens femininity or whether it heightens the

1
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rislc of cancer is an important, perhaps even a life-shaping, question
to the women facing the issue of ageing.

On issues relating to

health, most women are likely to seek, and follow, the advice of
their physician.

Others might read reports of, or indirectly learn

about, medical research on ERT.

Still others might turn to, or seek,

additional information from, various feminist and consumer groups
which give advice on health-related issues.

Finally some women will

be influenced by government pronouncements and literature on the ef
ficacy and safety of the drug.
about ERT will be made.

From these various sources a decision

Yet depending on which side of the Atlantic

Ocean women live on, that advice and the consequent ERT decision
ape likely to be quite different, even opposite, in nature.

Statement of Problem

This thesis is not a study of the safety and efficacy of ERT.
Rather it is a study of the social forces shaping the ERT controver
sy.

Our specific interest is in comparing and contrasting the ERT

debate in the United States and Great Britain.

In both countries

ERT decisions are made from the same scientific data base.

Yet

preliminary analysis indicates that the medical and the non-medical
aspects of the controversy vary independently, and in opposite direc
tion, in the two countries.
To describe and analyze these anomalies, initial consideration
is given to an historical analysis of the changing definitions of
menopause.

We investigate the origins of current medical views on
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the menopause, and try to determine why the menopause is seen as a
disease which needs routine treatment.

We then examine the various

loci of input into the ERT decision by focusing on cross-cultural
differences in (1) the medical research community, (2) physician
practices, (3) feminist/consumer groups, and (4) regulatory policy.

Cross-Cultural Design

Why study controversy?

The answer, according to recent schol

arship, is that controversy may offer a window through which the
more general social relations of science can be viewed.

Since con

troversies are usually played out within an adversarial framework,
scholars may treat disputes as data to assess the strengths and
weaknesses of opposing arguments (Mazur, 1981), or as a way to reveal
"...The special interests, vital concerns, and hidden assumptions of
the various actors" (Nelkin, 1979, p. 7).

In a theoretical and

methodological sense, controversies in science "seem to offer a
research focus premitting concurrent exploration of cognitive and
broad cultural factors" (Blume, 1977, p. 13).

And from an historical

view, the study of controversy may focus attention on the patterns
of interaction between the cultural and positivistic aspects of
science (Caplan, 1979).
These advantages notwithstanding, the study of controversy has
generally suffered from the weakness inherent in case studies.

With

out comparative data there is no way of separating the ideosyncratic
from the scientifically meaningful datum.

A few comparative studies
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of controversy now exist.

Leahy and Mazur (1978) have contrasted

the nuclear power, fluoridation and abortion disputes, while Petersen
and Markle (1981) have examined the scientific and cultural dynamics
of five cancer-related controversies.
methodologically limited.

Yet even these studies are

(See Markle & Petersen, 1981, for a

•

research strategy to ameliorate some weaknesses in the case study
design.)

By examining controversies within the same cultural set

ting, such designs must treat social structure and culture as
constants, rather than as variables in the analysis.

Thus is the

richness and potential of cultural explanations limited.
What is needed, clearly, is cross-cultural analysis of contro
versy.

When the scientific data are the same, and yet outcomes dif

fer, then social structural and cultural factors as shapers of
science cannot be ignored.

Almost a century ago Emile Durkheim

stressed the comparative method when he wrote:

"Comparative sociol

ogy is not a particular branch of sociology; it is sociology itself
insofar as it ceases to be purely descriptive [of a particular
society] and aspires to account for the facts" (1938, p. 139).
The power of cross-cultural design is evident in a few recent
studies.

In an analysis of witchcraft in Renaissance Europe, Currie

(1968) found that political and economic factors influenced the
extent and form of persecution.

Scott (1970) found that experts*

conception of blindness in the U.S. , Sweden, and Great Britain was
influenced by different socio-cultural factors.

In research similar

to our own study, Gillespie et al. (1979) posed the question:
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"Why

were two pesticides, Aldrin and Dieldrin, judged to be carcinogenic
in the U.S. but not in Great Britain when the same evidence was
available to public authorities in both countries?"

Four factors—

differentially developed environmental movements, differential
economic well-being, democracy of expertise, and differential "styles
of government"— seemed to account for some of the differences between
the two countries.

Theoretical Issues

Similar to Durkheim’s plea but more recent, Turner (1970) urged
that if social "scientists are to generate a body of theory and con
centrate their efforts on making theory more general and valid, com
parative cross-cultural research is absolutely essential" (1970, p.
4).

The ERT controversy is of considerable interest to the sociolo

gist not only because it shows how two countries might reach contra
dictory conclusions based on the same scientific data, but also
demonstrates how actors outside the scientific community might
develop divergent definitions (and suggested solutions) to the same
problem.

Thus this thesis can shed light not only on theoretical

debates in the sociology of science and knowledge, but also clarify
debates in social problems, social movements and deviance studies.
The social problems and deviance literature can be dichotomized,
based on Ritzer’s (1975) distinction, into two divergent theoretical
perspectives.

Those following the "social factist" tradition,

variously called "objectivist", "absolutist", or "positivist" (the

with p erm issio n of th e copyright ow ner. F u rth e r reproduction prohibited w ithout perm ission.
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term used here), hold that social problems and deviance are objec
tively given, intrinsically real, and lend themselves to scientific
analysis.

This position is perhaps best explicated by Manis who

defines social problems as "those conditions identified by scien
tific inquiry and values as detrimental to human well-being" (1976,
p. 25).

Thus the major focus of positivists is on the etiology and

control of social problems and deviance.
The other position is derived from Ritzer’s definitionist pers
pective, and variously termed "interactionist", "subjectivist",
and "social constructionist" (the term used here).

Social

constructionists are less concerned with the etiology question, but
instead focus on the social processes of defining and labelling pu
tative conditions and behaviors as problematic or deviant.

What

makes a behavior or condition distinctive depends not on objective
reality, but on the political process through which powerful interest
groups and/or segments of the public
definitions of reality.

are likely to impose their

Thus social problems and deviance are the

result of enterprise, and the products of certain people or groups
making claims based on their particular interests, values, and views
of the world (Becker, 1963; Conrad and Schneider, 1980; Schur, 1979;
Spector and Kitsuse, 1977).

As Mauss has summarized:

No social condition, however deplorable or in
tolerable it may seem to social scientists or
social critics, is inherently problematic. It
is made a problem by the entrepreneurship of
various interest groups, which succeed in winning
over important segments of public opinion to the
support of a social movement aimed at changing
that condition (1975, p. xvi).
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In the area of social movements, closely linked with social
problems and deviance, a similar dispute has developed in recent
years.

The positivist model, often referred to as a "strain" or

"discontent" perspective, holds that social movements arise because
of deep and widespread discontent.

Social conditions are such that

a severe strain develops between different segments of a given socie
ty.

The strain generates discontent, emotional anxiety and anomie,

resulting in social.disorder and conflict (Hoffer, 1951; Komhauser,
1959; Smelser, 1963).
In the past few years the resource mobilization model has cast
doubt on the traditional strain formulations.

This newer perspective

holds that conflict does not arise from disorganized anomic masses,
but from organized groups able to advance and defend their interests.
Discontent or strain is seen as relatively constant and is not suf
ficient to give rise to a social movement.

What accounts for in

surgency is the amount of social resources available to discontented
groups and their ability to effectively mobilize these resources to
upset the balance of power (Gamson, 1975; Oberschall, 1973; Tilly et
al., 1975).
The internal-external debate in the sociology of knowledge and
science has developed along lines similar to the positivist-social
constructionist split.

The internalist position viex*s the substance

of science as the result of rational, value-neutral activity, gov
erned by the internal laws and logic of science, but isolated from
external social forces.

Because the empirical relationships of the

R ep ro d u ce d with p erm ission of th e copyright ow ner. F u rther reproduction prohibited w ithout perm ission.

8

natural world are unchanging and universal, scientific knowledge
develops unidirectionally and evolves through the gradual accumula
tion of permanently valid conclusions (Hall, 1963; Mannheim, 1952).
As Gillispie (1962, p. 89) has summarized:

"I think it is obvious

that science, which is about nature, cannot be determined in its
content by the social relations of scientists."
The externalist position, on the other hand, contends that
scientific knowledge, as with all other knowledge, is socially
constructed and mediated by social and economic forces.

Mendelsohn

has presented an eloquent argument for this stance:
Science is an activity of human beings acting and
interacting, thus a social activity. Its knowledge,
its statements, its techniques have been created by
human beings. Scientific knowledge is therefore
fundamentally social knowledge. As a social activi
ty, science is clearly a product of a history and
of processes which occurred in time and in place
and Involved human actors....The techniques for
the proper study of science as a human activity
will thus encompass the historical and the socio
logical and be comparative in mode (1977, pp. 3-4).
The content of science is thus not immune from external factors,
but must be viewed within the social and political context of a
given time.

As MacLeod has written:

The shared values and normative goals of science of
a given time can, with time, fade from view as ex
plicit ideas which are part of the common culture,
and become part of the received wisdom of the
scientific field. In this event, external factors
become internalized (1977, p. 176).
It follows then, concludes MacLeod, "that we cannot usefully dispute
the causal influence of external factors on the content of science"
nor is there any indication that the course of science has devel
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oped "in any simple, direct or uniform fashion" (1977, p. 176).
To summarize, then, our comparative, cross-cultural analysis of
the ERT controversy ought to shed light on the foregoing theoretical
debates.

Since the same data base is used to make ERT decisions in

the United States and Great Britain, it would appear that objective
or internal factors are held constant.

Any divergences between the

two countries, such as the problematic nature of the menopause, or
the differential evaluation of the risk-benefit equation for ERT,
must be due to subjective or external factors.

Views which are

judged as "truth" might thus be shown to vary by time, place and so
cial context.

As Pfuhl has written:

Social reality is multiple rather than singular,
and given multiple realities, it is often contra
dictory rather than consistent. The elements com
prising social reality are in conflict rather than
harmony. Consistent moral definitions of things
may be said to exist only in the abstract. As they
apply to concrete events, these definitions are
highly variable, fluctuating from one setting or
context to another (1980, p. 36). (Emphasis in
original)
The remainder of this thesis, then, attempts to establish,
describe and explain the nature of these subjective factors and how
they have shaped the ERT controversy.
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CHAPTER II

HISTORICAL PERSPECTIVES:1
DEFINITIONS OF MENOPAUSE

CHANGING

Any attempt to understand the complexity of the current contro
versy over Estrogen Therapy will be deficient without an awareness of
the historical development of the medical profession's perception and
treatment of the menopause.

Health care for women in general, and

older women particularly, has been and still is a curious mixture of
myth and reality, based on commonly held perceptions of women's
changing roles, the changing roles of physicians and the interaction
of these factors.

Thus, a historical perspective of the treatment of

menopause is presented to set the context for this research and to
complement other components of this study.
Traditionally, historians of medicine have focused on the scien
tific and professional developments, or medicine as seen through the
lives of its most renowned practitioners.
been linear and cumulative:

The resulting picture has

medical history becomes a progression

of advances in theory and practice as influenced by scientific break
throughs, but insulated from social conditions (Verbrugge, 1976).
Historical studies of women and health care challenge this narrow,
"internal" perspective of science, and reveal a much more complex
i

and dynamic model.

The dialectical relationship between society and

medicine is forcefully demonstrated by women's health care.

Medical

views of women parallel societal ones and in turn legitimize them.
The study of menopause demonstrates that historically physicians
have served the interest of those in power, not only as healers but

10
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also as arbiters of morality and staunch supporters of the status
quo.

2
Women’s relationship to health care is distinctive:

the provider

for the most part is male, whereas the patient is female.
health care for women involves more than medical issues:

Thus
the phy

sician’s attitude toward women becomes an important variable.

This

relationship becomes more complex when the patient is a middle aged
woman.

The physician must not only deal with his attitude toward

women but also his personal and social attitude towards aging.
An historical analysis of medicine reveals that distinctive
theories, treatment and institutions for women have existed since the
beginning of scientific medicine.

At least since the Enlightenment,

philosophers have celebrated man as the "captain of his soul" and
"master of his fate".

Once again, as in Protagoras’ golden age of

Greece, "man" became "the measure of all things".
ty and free will were seen as inherent traits.
over matter", but not so for women.

Reason, rationali

For men it was "mind

Medical literature from the

eighteenth through twentieth century portrays woman's function, beha
vior and potential dependent on her reproductive organs.

Biology,

for woman, is destiny - whether it is determined by her uterus or her
"raging hormones".
The medical definition of menopause has been heavily influenced
by the social stigma applied to menopause.

In a society where

woman’s social usefulness is largely defined by her reproductive
capacity and sexual attractiveness, menopause, the loss of fertility
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and youth, is generally perceived as a dire event, a symbol of
decrepitude and decay.

The aging woman is desexed and concomitantly

stigmatized due to the loss of her primary social role.

The medical

literature on menopause reveals three consistent themes:

(1) meno

pausal symptoms as sin and decay, (2) as a psychological problem, and
(3) menopause as a deficiency disease.

Although these definitions

overlap and run throughout the entire time span, they vary in em
phasis during any given time period.

Before considering these

stages, we briefly examine the sexual politics of women in Victorian
medicine.

Women and Medicine in Victorian Society

During the later part of the eighteenth and the beginning of the
nineteenth century, the Industrial Revolution and the concomitant
development of capitalism brought about profound social changes in
both Western Europe and America.

With the triumph of the Market •sys

tem, the old unity of work and home, production and family life, was
irrevocably shattered.

The household, no longer a self-contained

unit, was reduced to a place of eating, sleeping, sex, and the care
of small children.

Life became experienced in two distinct spheres:

the ''public" sphere, dominated by men and ultimately governed by the
market; and the "private" sphere of the household relegated to women
(Ehrenreich & English, 1978).

Under the impact of rapid social

change and instability, the home came to be seen as an idyllic ref
uge from the competitive world of men.

Sex roles, particularly the

13

expectation of women, changed accordingly.

The perfect "lady"

limited her role to marriage and procreation, for which her "natural"
submission to authority and maternal instinct perfectly suited her.
This drastic constriction of woman's role was reinforced by the
romanticism of perfect womanhood.

The prevailing ideology defined

woman as naturally fragile, chaste, loving but not sexual, in need
of protection, morally superior but intellectually inferior to men.
By placing woman on a pedestal, she effectively lost the ability to
stand on her own two feet.

Sexual romanticism meshed ideally with

the needs of the merging economy which increasingly depended on the
3
nuclear household and individual domestic consumption.
The need to restrict and codify women's proper sphere intensi
fied as women began to question their narrow role.

The "woman ques

tion" as it came to be called, stirred controversy throughout the
nineteenth century (Stage, 1970).

As some women challenged the ideas

put forth by romanticism and demanded opportunities for education and
birth control, science rose to the defense of the status quo.
Science, the new faith of the century, provided the framework within
which the "woman question" was examined.

Men hopeful of preserving

the existing social relationships put forth medical and biological
arguments to rationalize traditional sex roles as rooted in anatomy
and physiology (Smith-Rosenberg & Rosenberg, 1973).

The Victorian

physicians assumed the roles and duties previously reserved for the
priest and minister, and held themselves responsible for the moral
and spiritual, as well as the physical health of society.

Medical

authority was brought against any elements which threatened the
stability of society (Haller & Haller, 1974; Stage, 1979; Vicinus,
1972).
As Stage (1979, p. 18) noted:
...the constriction of woman's sphere apparent on
the social level was paralleled in medical writing
by a constriction in the field of vision which led
doctors to focus, with obsessive concern, on
woman's organs of reproduction.
French historian Jules Michelet declared that each century had
its own great malady— leprosy in the thirteenth century, plague in
the fourteenth, and syphilis in the sixteenth.

Writing in 1868,

Michelet characterized the nineteenth century as "the age of the
womb" (Stage, 1972, p. 64).

"The Uterus, it must be remembered",

wrote Dr. F. Hollick in 1848, "is the controlling organ in the fe
male body, being the most excitable of all, and so intimately con
nected, by the ramifications of its numerous nerves, with every other
part" (quoted in Ehrenreich & English, 1978, p. 108).

Professor.

Hubbard, addressing a medical society in 1870, observed that it
seemed "as if the Almighty, in creating the female sex, had taken the
uterus and built up a woman around it" (quoted in Wood, 1973, p. 3).
For other medical theorists, it was the ovaries which determined
woman's physical, emotional and mental states.

The following state

ment written by Dr. W. Bliss in 1870 typifies this opinion:
Accepting, then, these views of the gigantic power
and influence of the ovaries over the whole animal
economy of woman,— that they are the most powerful
agents in all the commotions of her system; that on
them rest her intellectual standing in society, her
physical perfection, and all that lends beauty to
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those fine and delicate contours which are constant
objects of admiration, all that is great, noble and
beautiful, all that is voluptuous, tender, and en
dearing; that her fidelity, her devotedness, her
perpetual vigilance, forecast, and all those quali
ties of mind and disposition which inspire respect
and love and fit her as the safest counselor and
friend of man, spring from the ovaries,— what must
be their influence and power over the great vocation
of woman and the august purposes of her existence
when these organs have become compromised through
disease! (W. W. Bliss, 1870, p. 96). (Emphasis in
original)
Thus, it is not

surprising that any female disorder from headaches,

to hysteria and insanity where blamed on uterine or ovarian disease.
Dr. M. E. Dirix wrote in 1869:
Thus, women are treated for diseases of the stomach,
liver, kidneys, heart, lungs etc.; yet in most in
stances, these.diseases will be found on due inves
tigation, to be, in reality, no diseases at all,
but merely the sympathetic reactions or the symptoms
of one disease, namely, a disease of the womb (quoted
in Ehrenreich & English, 1978, p. 110).
Victorian medicine furnishes a remarkable example of how scien
tific knowledge reflects, rather than determines the moral biases of
an era.

Since woman’s reproductive organs supposedly governed every

sphere of her life, they came to be seen as a sacred trust, one that
she must constantly guard in the interest of the race (Stage, 1979,
p. 69).

The threat of disease was used as a sanction to enforce

traditional behavioral norms.

Physicians warned women if they

transgressed God's or nature's law, by attempting to enlarge their
sphere of action, they would pay a heavy price— their sexual organs
would rise up against them in retaliation.

This sentiment is cap

tured in the following quote written by a physician in 1873:
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Woman, in the interest of the race,, is endowed with
a set of organs peculiar to herself, whose complexi
ty, delicacy, sympathies, and force are among the
marvels of creation. If properly nurtured and cared
for, they are a source of strength and power to her.
If neglected and mismanaged, they retaliate upon
their possessor with weakness and disease, as well of
mind and body (quoted in Stage, 1979, p. 69).

Menopause as Sin and Decay

Medical theories served to warn women to limit their activities
to the home, otherwise disease, insanity, and even death would surely
follow.

The day of reckoning came with the onset of the menopause.

Victorian physicians advised endlessly on the dangers of menopause
and saw menopausal problems as the punishment for earlier sins.
Physicians invariably characterized it as the "Rubicon" in a woman's
life, and measured the extent of discomfort and disease by the
degree of "abuse" she had inflicted on her constitution (Haller &
Haller, 1974, p. 35).

Medical manuals blamed the frequency and

seriousness of disease during this period upon "indiscretions" of
earlier life.

Gynecologist John Kellog wrote in 1883 that the woman

who transgressed nature's law "will find this period a veritable Pan
dora's box of ills, and may well look forward to it with apprehension
and forboding" (quoted in Haller & Haller, 1974, p. 135).

A woman

"transgressed nature's law" when she ventured outside her narrowly
prescribed role.

Although physicians postulated a number of ex

planations for the heightened disease incidence of the older female,
"the most significant cause of woman's menopausal disease", according
to historian Smith-Rosenberg, was that:
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virtually every doctor believed, lay in violation
of the physiological and social laws dictated by
her ovarian system. Education, attempts at birth
control or abortion, undue sexual indulgence, a too
fashionable life style, failure to devote herself
fully to the needs of husband and children— even
the advocacy of woman's suffrage— all might guaran
tee a disease-ridden menopause (1974, p. 30).
Even if a woman did not "transgress" in earlier life, a momen
tary lack of judgment in old age— e.g., engaging in sexual inter
course during or after menopause1
— could lead to hemorrhaging, ovarian
tumor, or insanity.

British physician John Tilt, in his widely read

text concerning the menopause, wrote in 1871:
My experience teaches me that a marked increase in
sexual impulse at the change of life is a morbid im
pulse. Whenever sexual impulse is first felt at the
change of life, some morbid ovario-uterine condition
will be found to explain it (quoted in Smith-Rosenberg,
1974, p. 31).
And in 1897, Dr. Andrew Currier warned that "irregular and unwomanly
occupations, alcohol, poverty, opium, typhoid and excessive sexual
indulgence" could all bring on a premature and difficult menopause.
According to historian Peter Stearns, European physicians in the
18th and 19th century believed that women decayed at menopause and
that it marked the beginning of old age; men were not seen as old for
another 15 to 20 years.

Women were viewed as being sick from meno

pause until death, and physicians found their appearance as "dis
graceful".

Deprived of function, stated a French physician, "an old

woman is for nature only a degraded being, because she is useless to
it.

Women could survive only if they abandoned the frivolous plea

sures dominating their younger years" (quoted in Stearns, 1979, p.
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45).

American physicians gave similar advice.

"We insist", wrote

Dr. Taylor in 1872,
that every woman who hopes for a healthy old age
ought to commence her prudent cares as early as
the 40th year or sooner.... She should cease to
endeavor to appear young when she no longer is so,
and withdraw from the excitements and fatigues of
the gay world (quoted in Smith Rosenberg, 1974, p.
31).
Therefore, sex as the definer of women, marked off an early old
age by its presumed disappearance.

Once sexual function was lost,

care should be taken not to revive it.

One physician emphasized the

dangers of sleeping upon a feather bed for menopausal women.

Feather

beds might
...excite the generative organs, which should henceforth.be left, as far as possible, in a state of in
action .... A woman at this time should avoid all
such circumstances as might tend to awaken any erotic
thoughts in the mind, and reanimate a sentiment
that ought rather to become extinct, such as the
spectacle of lascivious figures, the reading of pas
sionate novels, and, in fine, every thing calculated
to cause regret for charms lost that lost, and en
joyments that are ended for ever (quoted in Page,
1977, p. 67).
Historian Smith-Rosenberg also commented on the Victorian physician's
revealing attitude toward aging women:
Male physicians displayed a revealing disquietude
and even hostility when discussing their menopausal
patients. In the medical literature, the menopausal
woman often appeared as ludicrous or physically
repulsive. Edward Tilt for instance, claimed that
she characteristically has a "dull spudid look",
was "pale or sallow" and tended to grow a beard on
her chin and upper lip. Doctors scoffed at women
who, long sterile or just married at menopause, be
lieved themselves pregnant. These women, doctors
commented heartily, suffered from a little flatu
lence, somewhat more hysteria, and most of all
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obesity. Their fantasied fetus, another doctor
joked, was just their belly's double chin (1974,
p. 31).
Somewhat less hostile, Dr. Meings mourned a woman's lost charm and
"feminine grace" at the "turn of life":
There is something melancholy in the conviction,
that must attend the final cessation of the menses,
of a decadence of the constitution. The subject
of such a conviction is compelled to admit that she
is now become - what? an old woman! ... The pearls
of the mouth are become tarnished — the haylike
odor of the breath is gone, the rose has vanished
from the cheek, and the lily is no longer the vain
rival of the forehead and neck. The dance is pre
posterous, and the throat no longer emulates the
voice of a nightingale (quoted in Page, 1977, p.
64).
Even if.the Victorian woman had led an exemplary life, she was
not exempt from a host of ills at the menopause.

Female problems al

so developed because of the retention of humors which could no longer
escape through menstruation.

It was such a "plethora" or suffusion

of the body with fluids which also was believed to cause a host of
diseases.

Following the notion of this ancient plethora theory, one

physician labeled the uterus "the sewer of all the excrements exist
ing in the body" (quoted in Stage, 1979, p. 70).

The host of dis

eases that might develop as a result of the final cessation of the
menses included, proclaimed Dr. Tilt,
...almost all the ills the flesh is heir to:
flushes, dyspepsia, diarrhea, vaginitis, vaginal
inflammation, prolapsed uterus, rheumatic pain,
paralysis, apoplexy, ersipilas, uterine hemorrhage,
tumors, uterine and breast cancer, tuberculosis,
scrofula, diabetes. Also irritability, depression,
hysteria, melancholy, emotional withdrawal, and in
sanity (quoted in DeLorey, 1981, pp. 10-11).
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Victorian physicians practiced a variety of treatments for the
problems of the menopause, but the most common one was "local treat
ment"— remedies specifically directed at the womb.

Since almost all

disorders were traced back to the reproductive organs, women dis
playing such a variety of symptoms as a simple headache or irritabil
ity, hot flashes, to prolapsed uterus and even cancer, were subjected
to local treatment.

Therapy consisted of four stages, although not

every case went through all four:

manual manipulation, "leeching",

"injections", and "cauterization".

Historian Woods recounts these

four stages:
Dewees and Bennet, famous English gynecologists
widely read in America, both advocated placing
leeches right on the vulva or the neck of the
uterus, although Bennet cautioned the doctor to
count them as they dropped off when satiated, lest
he "lose" some. Bennet had known adventurous
leeches to advance into the cervical cavity of the
uterus itself, and noted: "I think I have scarcely
ever seen more acute pain than that experienced by
several of my patients under these circumstances".
Less distressing to the twentieth century mind, but
perhaps even more senseless, were the "injections"
into the uterus advocated by these doctors. The
uterus became a kind of catch-all, or what one
exasperated doctor referred to as a "Chinese toy
shop": Water, milk and water, linseed teas, and
"decoction of marshmellow ... tepid or colid" found
their way inside nervous women patients. The
final step, performed at this time, one must remem
ber, with no anesthetic but a little opium or al
cohol, was cauterization, either through the
application of nirrauts of silver, or in cases of
more severe infection, through the use of the much
stronger hydrate of potassa, or even the "actual
cautery", a "white-hot iron" instrument (Wood,
1974, p. 4).
One must remember that this last treatment was used even if there was
no uterine infection, and thus subject to great abuse.

Alice Stock-
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ham, one of a handful of women physicians at that time, severely
criticized local treatment:
The severe caustic treatment that has been so
universal in these affections is greatly to be
deprecated. There are fashions in medicine as in
other things, and the one fashion the last twen
ty-five years has been local treatment for
diseases in women. In no department of medical
practice has the physician's prerogative been more
abused. For the slightest ailments the severest
applications are often employed (Stockham, 1893,
pp. 269-270).
Stockham urged women to "protest positively and persistently against
the burning, probing and scarifying of the womb".

This woman

physician condemned local treatment, bleeding and blistering as a
"relic of the past" and "contrary to science and common sense"
(Stockham, 1893, p. 272).

She also had sympathy for the plight of

her contemporary sisters,
... is is easy for a sensitive woman to persuade
herself that her afflictions from the toothache
downward, are due to diseases of the womb. Here
comes in the charlatan, to exaggerate her diseases,
if any, and to beguile the patient with promises
of cure. The speculum, the caustic and the knife
look like work, and she thinks something is being
done for her (Stockham, 1893, p. 291). (Emphasis
in original)
Anticipating the charges of current American femininists, Stockham
states that the menopause is a natural event that for the healthy
woman should be attended by no unpleasant symptoms.
The change of life is one of the scape-goats of
physicians ... If any lady from thirty-five to
fifty-five years of age is afflicted with
dyspepsia, neuralgia, rheumatism, consumption or
any other ailment, the doctor, not being able to
cure her, pronounces it the meno-pause, or "change
of life" (Stockham, 1893, p. 276).

22
Catherine Ester Beecher also crusaded against local treatment,
and in her Letters to the People on Health and Happiness (1855) saw
the treatment roughly equivalent to rape.

This "evil" is performed,

she explained "with bolted doors and curtained windows, and with no
one present but the patient and operator" (1855, p. 136).
American gynecologist Andrew Currier, writing in the 1890's also
attacked his male colleagues for their negative attitude towards
menopause and called them "bleeders, pukers, and purgers".

Even

though he still advocated leeching as an effective remedy for sexual
arousal caused by congested genitals, in his book The Menopause
(1997), he otherwise condemns local treatment as obsolete.

Riding on

the wave of progress evoked by English physician Robert Battey's inL

vention of "female castration"
menopause:

in 1872, Currier advocated surgical

the removal of any organs that directly affect the

menstrual process (Currier, 1897, pp. 230-283).

He advised his

colleagues to be thorough, "for if you remove the fallopian tubes,
then you might as well remove the ovaries, because without the tubes
the ovarian function is gone, and remove the whole ovary instead of
just part

of one".

But much of the success depends on the'judicious

selection of cases ... some patients would be incurable by any opera
tion, and this would include some who had long been subject to vicious
habits, to the use of alcohol, chloral, opium, etc." (Currier, 1897,
p. 249).
Entrenched as the medical attitudes toward women were, at the
turn of the century, a young Viennese physician— himself a product of
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the Victorian era-revolutionized the theories of the etiology of
female complaints.

Sigmund Freud's ideas led to the reinterpretation

of the menopause.

Menopause as a Psychological Problem

Although physicians of the nineteenth century saw insanity and
hysteria as frequently associated with the menopause, the immediate
cause was believed to be a diseased uterus or ovary.

In the early

twentieth century the emphasis shifted from organic causes to psycho
genic ones.

The advent of Freudian theory, the subsequent mental

health movement, and the.synthesis of psychotropic drugs all set the
stage for recasting virtually all "female complaints" into the psycho
logical arena.
By the end of the 19th century, wrote Stern and Prados (1945, p.
358), the notion that personality disorders were "menopausal" had
grown to the point that some psychologists referred to personality
change as the first sign of approaching menopause.

Although Freud

himself did not extensively write on the menopause, it was a stage
of potential crisis in his theory.

He believed that previously un

disturbed women could become neurotic, since the end of menstruation
allowed for a re-emergence of the castration complex.

Often, Freud

noted, menopausal women "become quarrelsome and obstinate, petty and
stingy, show typical sadistic and anal-erotic features which they did
not show before" (quoted in Silberman, 1950).
Freud's perception of menopause were fully developed by Deutsch
(1945) and Benedek (1950), whose theories had great influence on
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subsequent writings.

In Psychology of Women, Deutsch viewed meno- .

pause as the third of the infantile stages (the second being puberty).
During both of these traumatic stages, women act out certain uncon
scious fantasies.

Deutsch insisted that during menstruation women

experience fears of castration and lost children and during menopause
*

fantasies of rape and prostitution.

Puberty, according to Deutsch,

signifies the moment a woman becomes the "servant of the species,"
whereas at menopause woman's service to the species ends.

The woman

becomes socially useless with the loss of her reproductive function.
Menopause becomes a critical period, since "mastering the psycho
logical reactions to organic decline is one of the most difficult
tasks of woman's life" (1945, p. 436).

Homosexual panic is also fre

quently experienced and the yearning for a son becomes obsessive as
the increased need for him is frustrated.
Almost every woman in the climacterium goes through
a shorter or longer phase of depression. While the
active women deny the biologic state of affairs,
the depressive ones overemphasize it....hypochondric
ideas appear which in an overwhelming majority of
cases relate to the genital organs (1945, p. 437).
These depressive moods may disappear or turn into serious melan
cholia.

Deutsch wrote that "feminine-loving" women have an easier

time during menopause than "masculine-aggressive" ones.

Engaging in

a meaningful career might serve as a protection against the biological
trauma of the climacterium, but not without running a risk.

"If their

social and professional interest have taken excessive hold of them,
these women are threatened in the climacterium by the danger I call
'pseudomasculinity'" (1945, p. 476).

Pseudomasculine women are not
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truly masculine, according to Deutsch, but are women whose feminine
eroticism or maternal love has not fully developed.
Deutsch's influence can be seen in the writings of the well
known psychoanalyst Eric

Erickson.

For example, Erickson wrote

that when a woman’s womb is "empty" she experiences pain.

Her grief

for lost children is experienced at each menstruation and becomes a
"permanent scar" at menopause (1968, p. 278).
In a similar Freudian tradition, Benedek (1950a) interpreted
menopausal symptoms as resulting from a threat to the ego.

The life

situation at the time of the menopause becomes complex and demanding:
children leave, sons marry, and sexual needs between husband and wife
change.

When a woman no longer can respond to difficulties the

way she did in the past, "her ego alien emotional responses threaten
her."

Not all women, Benedek believed, experienced menopause with

the same degree of difficulty.

For example women who have never

borne children will have more intense reactions.

The severity of

psychological symptoms, Benedek asserted, are "motivated by the psychosexual history of the individual," and are the result of earlier
deviations.

In women who experience problems with menopause:

1.

The bisexual disposition played a disturbing role in the
development and

2.

The psychic economy was dominated— much like that of men—
by strivings of the ego rather than by the primary emo
tional gratifications of motherliness (1950b, pp. 239-240).

The message sounds familiar:

women who reject their "feminine

role" will find retribution waiting for them at the menopause.
Another psychologist described the symptoms of the menopause as a
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...[P]rofound sense of internal inadequacy...reflec
ted in the symptoms of intermittent depression or
blues which appear characteristic of the menopause.
The patient will complain of sudden, involuntary,
easily precipitated crying spell, or a sensitivity
to rejection, and an intolerance of loneliness.
She reacts with bitterness and resentment to this
inadequacy she experiences within herself and often
projects this self-incriminating anger and hostility
onto her husband, blaming the casualness of the
familiar husband for her feelings of self-deprication (Kerr, 1968).
Not only husbands but also children are frequently depicted as the
victims

of menopausal neurosis.

social stereotype for

The menacing mother-in-law is amajor

the menopausal woman.

Unless they havethe

right outlet, wrote one physician, menopausal women are apt to become
"mischief makers," developing a neurotic interest in their married
sons and daughters and often becoming a great menace as meddlesome
mothers-in-law (Sadler and Sadler, 1938, p. 296).
Rogers (1956) in a comprehensive review of the medical litera
ture on menopause published in the New England Journal of Medicine,
concluded that the menopause was a critical time since a woman is
"forced to retire from her primary role" and since few women were
prepared to deal with this role loss, psychotherapy was advocated to
help women adjust to this crisis. Osofsky and Seidenberg (1970), in a
more critical analysis of the psychological literature on menopause,
charged that psychoanalysts (in the Freud and Deutsch tradition) fre
quently viewed menopause as a time of "mortification and uselessness"
since the woman's "service to the species" is over.

The authors

noted that:
In contradiction to the male, female psychology is
seen as being dependent on biology. Youth, attrac
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tiveness, sex and motherhood are viewed as the
important roles for women...This thinking has in
fluenced the therapy offered menopausal symptoms.
Physical symptoms have been treated psychologically
and psychogenic symptoms, physiologically (1970,
p. 611).
As in the 19th century, biology is still destiny.

Given the

survival of this belief, it is not surprising that there is a double
standard for mental health— one for men and one for women.
et al. (1970) empirically validated this double standard.

Broverman
In a sur

vey of 79 therapists, respondents were asked to list traits felt to
be characteristic of healthy males, healthy females, and healthy
adults (sex unspecified). Traits for healthy males and adults were
found to be congruent, but healthy females were seen as less inde
pendent, more submissive, more easily influenced, less aggressive,
less competitive, more emotional, more vain, and less objective.
These same traits were judged pathological in males and adults.
conclusion is clear:

a "healthy" woman equals a sick adult.

The

The

woman who rejects her "feminine role" becomes subject to medical con
trol.'*

A watered-down version of psychoanalytic theory is evidenced in
the writings of many endocrinologists and gynecologists.

In the

December, 1944, Journal of Clinical Endocrinology, a special issue
devoted to the menopause, various physicians discussed the implica
tions of hormone therapy.

"In almost every case," wrote Engle in the

introduction to the issue, "the physician who gives advice or recom
mends therapy to a woman of menopausal years must deal first and
primarily with a disturbed patient and only secondarily with an in-
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dividual having lowered estrogen reserves" (Engle, 1944, p. 569).
(emphasis added)

Another physician, critical of estrogen treatment,

emphasized the psychological problems:
[IJs it any wonder that a third to half of them
[menopausal women] suffer from "nervous instability"?
The actual cessation of menstruation brings realis
tically to a woman the undeniable fact that she is
aging, that her reproductive potentialities are
leaving her and that she has therefore fulfilled
her physiologic usefulness in life....It is there
fore apparent that the climacteric is a condition
of many facets— only one of which is estrogen de
pletion. As Ross says, it cannot be called a
disease, unless the process of aging is called a
disease; yet the insecurity, instability, depression
and introspection which frequently accompany this
period of life must be treated (Buxton, 1944, pp.
591-592). (Emphasis added)
Here the treatment of choice was primarily barbiturates, especially
phenobarbital, followed by estrogen replacements if necessary.
Another contributor to the issue counselled the clinician:
"Every physician who attempts to treat a woman in the menopause syn
drome should be prepared to undertake a species of psychotherapy"
(Sevringhaus, 1944).

And in the final article of the series, a Har

vard endocrinologist noted:
The essential psychosomatic nature of clinical endo
crinology comes out with particular clarity in case
of the climacteric disorders.... Even in case of the
most effective specific hormone therapy, it is often
an open question to what extent the benefit is de
termined by so-called psychological reactions rather
than by direct corrective influences upon the organic
processes.... Even when the physician regards him
self as an uncompromising organicist, the feeling
of security.that his ministrations confer upon the
patient is often the most potent factor in his
therapy (Hoskins, 1944, p. 605).
This physician viewed anxiety as the central feature of the menopause,
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caused by a threat to the ego which in turn is- the result of castra
tion fears.

The recommended' treatment for severe cases was psycho

therapy; milder cases could be managed by "drug sedation" and sympa
thetic counseling.

If the woman suffers from a loss of self-worth

because of decreasing opportunities for accomplishments, then,
In such cases ways should be pointed out in which
she can extend her sphere of productive activity.
But more, she may need to have instilled into her
enough enthusiasm to overcome a considerable de
gree of initial apathy. What form the activity
takes is largely immaterial...It may be tray-,
painting, gardening, sitting with a neighbor's
baby, bridge, bandage-rolling or what-not.
....Another approach to the "threatened ego" is
actually to expand and fortify it by the various
resources of sociability, ie, of "identification."
Direct the patient into the way of life in which
she has increasing use for the pronoun "wew and
less for "Iu (Hoskins, 1944, p. 609).
Psychoanalyst Benedek urged gynecologists to join in the search
for signs of "rejection of femininity":
...women incorporating the value-system of a modern
society may develop personalities with rigid egodefenses against their biological needs. The con
flicts which arise from this can be observed clini
cally not only in the office of the psychiatrist,
but also in the office of the gynecologist and even
the endocrinologist (1952, p. 527).
That gynecologists took this challenge seriously is evidenced in the
introduction to a 1962 monograph, The Gynecological Patient:

A Psy

cho-Endocrine Study:
We feel the discipline [gynecology] should embrace
those disturbances in function or structure of any
part of the female organism that influence or are
affected by the performance of the reproductive sys
tem. We are impressed in particular with the dictum
that much of the physical and mental health of the
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individual woman can be properly understood only
in the light of her conscious or unconscious
acceptance of her feminine role (Sturgis and
Menzer-Benaron, 1962, p. xiv).
That they serve as agents of social control is well understood by
these two gynecologists.

In the past, they argued, the general prac

titioner had been "friend, guardian and teacher" of his patient:
With the priest or pastor, he stood as a bulwark
against illegitimacy, abortions and divorce.
Today, in the medical profession, obstetricians
and gynecologists are perhaps best able to fill
this position (Sturgis and Menzer-Benaron, 1962, p.
238).
The belief that menopausal problems are largely neurotic respon
ses to lost fertility and lost attractiveness or the result of rejec
ted femininity has been incorporated into gynecological training.
Posner (1979), in a content analysis of 29 gynecological texts, found
that the prevailing view was that menopausal symptoms are "all in the
head."

Such labels as "menopausal syndrome" and "empty-nest syndrome"

receive disproportionate attention, and physicians are repeatedly
urged to look for "rejection of femininity."

6

In addition to biased medical training, the role of the pharma
ceutical industry cannot be overlooked.

Psychological explanations

for menopausal problems were reinforced by what Silverman and Lee
(1974) called the "Pharmaceutical Revolution":

the synthesis and

manufacture of a large number of psychoactive drugs.

Since the 1930s

the prolific synthesis of these drugs has virtually revolutionized
drug-making and drug-taking in the United States.

The American

Medical Association’s change in policy in accepting more pharmaceu
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tical advertising in the late fifties (Conrad, 1975) was conducive to
an explosion of advertisements promoting these drugs.
These advertisements in medical journals portray women as
frustrated, anxious, neurotic, depressed and even suggest to doctors
that they can "help" women adjust through drugs to an uncomfortable
sex-typed role or get rid of elderly women patients who are becoming
a "fixture" in their waiting rooms (Seidenberg, 1976).

Physicians,

like everyone else, appear to be influenced by advertisements which
reflect prevailing social norms, and spend very little time investi
gating the therapeutic merits of a drug.
In a study by Linn and Davis (1972) the large majority of phy
sicians reported the importance of drug ads and company detailmen
in selecting drugs for their patients.

With medical school training

emphasizing the psychosomatic nature of female complaints (Howell,
1974; Posner, 1979; Scully and Bart, 1973) and pharmaceutical adver
tisements reinforcing those beliefs, it is not surprising that the
"menopausal syndrome" became the dominant diagnosis to be treated
with tranquilizers.

Menopause as a Deficiency Disease

During the eighteenth and nineteenth century conceptions of
health and illness included viewing the body as a closed system of
vital energy.

Health was defined in terms of a dynamic equilibrium

and balance which, in turn, was thought to be a product of the in
dividuals' integration (or conformity) to the larger moral and social
environment.

Activities which made unusual, excessive (immoral)
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demands on the body would lead to depletion, debility and disease.
Thus immorality was believed to be a cause of sickness and disease
(Conrad & Schneider, 1980).
With the advent of the germ theory, disease came to be viewed as
a discrete entity, with specific causes which called for specific
treatments.

This reductionist view of disease was widely accepted in

the twentieth century.

With increased knowledge and new perceptions

of disease, the physician was able to diagnose and treat ahost
"new"

diseases.

of

As Freidson pointed out, in these activitiesthe

physician can be seen as a moral entrepreneur:
[Medicine] is active in seeking out illness. The
profession does treat the illnesses laymen take to
it, but it also seeks to discover illness of which
laymen may not even be aware. One of the greatest
ambition of the physician is to discover and
describe a "new" disease or syndrome and to be
immortalized by having his name used to identify
the disease. Medicine, then, is oriented to seeking
out and finding illness, which is to say that.it
seeks to create social meanings of illness where
that meaning or interpretation was lacking before.
And insofar as illness is defined as something
bad— to be eradicated or contained— medicine plays
the role of what Becker called the "moral entre
preneur" (1970, p. 252).
Although menopause in the Victorian period had been defined as a
cause of, or being caused by disease, menopause itself had not been
defined as a disease.

During the 1920's and 1930's, however, a poten

tial treatment became available with the isolation and synthesis of
estrogen, a general name for three female hormones (estradiol, estrone
and estriol). If estrogens were to become the cure,
the disease?

As estrogen

what was to be

therapy became widespread, it followed that
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menopause .had to be seen as a disease.
The earliest interest in hormone replacement grew out of efforts
to find a cure for male impotency (Page, 1977).

In 1889 a French

physiologist reported to the Societe de Biologie in Paris that he had
injected himself with extracts from animal testicals and had experi
enced renewed vigor and rejuvination.

Four years later another

French scientist used an ovarian extract injection to treat a female
patient for menopausal "insanity."

And in 1896 a German doctor desi—

cated ovaries for treatment of menopausal symptoms at the Landau
Clinic in Berlin (Buxton, 19A4). In the later 1920s Allen and Doisey
isolated and crystallized theeline (later known as estrone) from the
urine of pregnant women (Page, 1977).

In 1932 Drs. Samuel Geist and

Frank Spielman described in the American Journal of Obstetrics and
Gynecology their efforts to treat menopausal women with theeline
(estrone).

Such treatments, however, were expensive and the supplies

limited since the drug was derived from human sources.
These problems were solved in 1936 when Marker and Oakwood de
veloped a synthetic form of estrogen, known as diethylstilbesteral
(DES). This cheap and potent hormone substance could be made
readily available to a large number of women and paved the way for
the development of the contraceptive pill.

The last step in the de

velopment of hormone therapy occurred in 1943 when James Goodall de
veloped an estrogen extract from the urine of pregnant mares.

Termed

conjugated equine estrogen and manufactured under the brand name of
Premarin, it was only about half as potent as synthetic estrogen, but
it created fewer unpleasant side effects (Page, 1977).
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With a readily available treatment, the stage was set for the
"discovery" of a disease.

All that was lacking was a moral entre

preneur to lead the crusade for the redefinition of menopause.

This

role was filled by the Brooklyn gynecologist Robert A. Wilson.

As

head of the Wilson Research Foundation, his writings were crucial to
the acceptance of menopause as a "deficiency disease" and the largescale routine administration of Estrogen Replacement Therapy" (ERT).
Wilson claimed that through his extensive research he discovered that
the menopause was a hormone deficiency disease similar to diabetes
and thyroid dysfunction.

In a 1962 article published in the Journal

of the American Medical Association, he claimed that estrogen preven
ted breast and genital cancer and other problems of aging.
though the methodology was weak,

7

Even

it launched a campaign to promote

estrogens for the prevention of menopause and age-related diseases.
By 1963, in the Journal of the American Geriatrics Society,
Wilson was advocating that women be given estrogens from "puberty
to grave."

Crucial to the popular acceptance of the disease model of

menopause was his widely read book Feminine Forever (1966).

Here

Wilson claimed that the menopause is a malfunction which threatens
the "feminine essence."

He described menopausal women as "living

decay" but menopausal women need not dispair:

ERT could save them

from being "condemned to witness the death of their womanhood."

He

further proclaimed that the menopause and aging could be allayed with
ERT and listed 26 physiological and psychological symptoms— including
hot flashes, osteoporosis (thinning of bone mass), vaginal atrophy
(thinning of vaginal walls), sagging and shrinking breasts, wrinkles,
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absent mindedness, irritability, frigidity, depression, alcoholism
and even suicide— that the "youth pill" could avert.
Wilson also was aware of the physician’s potential and even man
date for social control.

In his chapter titled "Menopause— The Loss

of Womanhood and Good Health" the first paragraph states:
...I would like to launch into the subject of meno
pause by discussing its effect on men. Menopause
covers such a wide range of physical and emotional
symptoms that the implications are by no means con
fined to the woman. Her husband, her family, and
her entire relationship to the outside world are
affected almost as strongly as her own body. Only
in this broader context can the problem of the
menopause— as well as the benefits of hormonal
cure— be properly appreciated (1966, p. 92). (Em
phasis added)
Wilson gives an example of how he helped a distressed husband who came
to him for help with the following complaint:
She is driving me nuts. She won't fix meals. She
lets me get no sleep. She picks on me all the time.
She makes up lies about me. She hits the bottle
all day. And we used to be happily married (1966,
p. 93).
Wilson tells how the wife responded well to "intensive" estrogen
treatment and in no time resumed her wifely duties.

In another chap

ter Wilson conjures up visions of "Steppford Wives":
In a family situation, estrogen makes women adap
table, even-tempered, and generally easy to live
with. Consequently, a woman's estrogen carries
significancy beyond her own well-being. It also
contributes toward the happiness of her family and
all those with whom she is in daily contact.
Even frigidity in women has been shown to be related
to estrogen deficiency. The estrogen-rich woman,
as a rule, is capable of far more generous and
satisfying sexual response than women whose femini
nity suffers from inadequate chemical support (1966,
p. 64).
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A number of other prominent gynecologists supported Wilson's
claims. For example, Shirwin Kaufman in The Ageless Woman described
menopausal symptoms as the result of hormone deficiency and lamented
Many women are obviously in need of estrogen re
placements but are so afraid of "hormones" that
it requires a good deal of explanation to persuade
them that estrogen does not cause cancer and may,
on the contrary, make them feel much better (1967,
p. 61).
Kaufman regretted that some of his colleagues also share this
unwarranted fear of cancer:
Some doctors prescribe estrogens reluctantly....
Historically, and too often hysterically, estro
gens have been endowed with malignant potentiali
ties. Paradoxically, it has been pointed out
that even conservative physicians may not hesitate
to give sedatives or tranquilizers, yet they stop
at the suggestion of estrogen replacement therapy.
This is baffling to a good many doctors (1967, p.
67).
Kaufman confessed that "Years ago, I used to discontinue such treat
ment (ERT) after a few months," but "today I am in no rush to stop"
(1967, p. 64).
Best-selling author David Reuben proclaimed in Everything You
Wanted to Know About Sex:

As estrogen is shut off, a woman comes as close as
she can to being a man. Increased facial hair,
deepened voice, obesity, and decline of breasts
and female genitalia all contribute to a masculine
appearance. Not really a man but no longer a
functional woman, these individuals live in.a
world of intersex. Having outlived their ovaries,
they have outlived their usefulness as human
beings (1969, pp. 287-288.
But women need not dispair:

with estrogen replacements they can

"turn back the clock" and adequate amounts of estrogens throughout
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their life will protect them against breast and uterine cancer
(1969, p. 290).
Another crusader for ERT, Helen Jern, a gynecologist at the New
York Infirmary, published a book of case studies proclaiming the
miraculous recoveries made by elderly women placed on ERT:
I know the remarkably beneficial effect of estrogen
as energizer, tranquilizer and anti-depressant. I
know that it stimulates and maintains mental capacity,
memory, and concentration, restores zest for living,
and gives a youthful appearance...Hormone therapy
once begun, should be continued throughout a
woman’s lifetime. It is my firm belief that many
female inmates of nursing homes and mental institu
tions could be restored to full physical and mental
health through adequate hormone therapy (1973, p.
156).
Robert Greenblatt (1974), former President of the American
Geriatrics Society, has claimed that about seventy-five percent of
menopausal women are "acutely estrogen deficient and advocates ERT
for them, even if they are without symptoms.

Echoing these senti

ments, a San Francisco gynecologist stated:
I think of the menopause as a deficiency disease
like diabetes. Most women develop some symptoms
whether they are aware of them or not, so I
prescribe estrogens for virtually all menopausal
women for an indefinite period (quoted in Brody,
1975).
Meanwhile throughout the late 1960s and early 1970s Wilson’s
book was excerptedwidely in traditional women’s journals and over 300
articles promoting estrogens have appeared in popular magazines
(Johnson, 1977).

During the same period, ERT products were widely

advertised in medical literature and promotional material as amelioratives for a variety of psychological, as well as somatic, problems.
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For example one ad depicted a seated women clutching an airline
ticket, with her impatient husband standing behind her glancing at
his watch.

The copy reads:
Bon Voyage? Suddenly she’d rather not go. She’s
waited thirty years for this trip. Now she just
doesn't have the "bounce." She has headaches, hot
flashes, and she feels tired and nervous all the
time. And for no reason she cries.

Another ad promoted ERT "for the menopausal problems that bother him
the most."

And an ad for Premarin stated:

"Any tranquilizer might

calm her down...but at her age, estrogen may be what she really
needs" (cited in Seaman & Seaman, 1977, pp. 281-282).
tisements paid off:

Such adver

between 1962 and 1973 dollar sales for estrogen

replacements quadrupled; in 1975 alone 25 million prescriptions were
written for ERT products, amounting to some $80 million in sales
(Wolfe, 1979).
The year 1975 was a watershed for ERT:

sales were at an all-

time high and physicians routinely used ERT to treat a wide variety
of menopausal symptoms.

In short, ERT had become one of the main

stays of medical practice.
change.

Yet within a few short years this was to

The prevailing definition of menopause and ERT were to be

challenged, not only from within, but from a variety of sources out
side, the medical community.

A description and analysis of the

challenge follows in the next chapter.

Summary and Conclusion

The foregoing literature shows that the medical definitions of
menopause fall into three broad categories:

(I) menopause as sin and
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decay; (2) as a psychological problem; and (3) as a deficiency
disease.

Although these three themes permeate the whole time period

examined, differential emphasis has been specific to historical
periods.
In the eighteenth and nineteenth century, physicians depicted
the menopause as disease-ridden and attributed the severity and fre
quency of symptoms to indiscretions of earlier life.

In the early

twentieth century, psychogenic explanations began to vie for domi
nance.

Freudian theory laid the groundwork for viewing menopausal

symptoms as neurotic responses to lost fertility or rejection of fem
ininity.

After the synthesis of a cheap estrogenic substance, the

deficiency disease model gained prominence and was widely accepted
by the early 1970's.
Despite the changing perception of the etiology of menopausal
symptoms and the treatment of choice varying from leeches to estro
gen, there are several underlying, persistent themes:

tial and function are biologically destined;

8

women's poten-

rejection of the

feminine role will bring physical and emotional havoc; women's worth
is determined by fecundity and sexual attractiveness; and aging women
are repulsive and useless.
These medical definitions can be seen as collective and politi
cal achievements, rather than inevitable products of the evolution
and progress of science.

Powerful social groups can construct and

define reality and impose their collective definitions on less
powerful groups.

Throughout the time-span examined, the medical

profession had defined menopause as a pathological and stigmatizing
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event.
Yet there is evidence that the subjective experience of women
has not always been congruent with the physicians' constructed real
ity.

Carroll Smith-Rosenberg, in an analysis of Victorian women's

letters^ diaries, and unpublished manuscripts, found that some women
viewed menopause as a release from the bondage of menstruation and
pregnancy.

She quotes social reformer and suffragist Eliza Famham,

writing in the 1860s, that for many women menopause was a time of
"secret joy", of spiritual unfolding, and of "super-exaltation".
The stigma attached to menopause, she attributed to "masculine er
ror" (Smith-Rosenberg, 1974, p. 33).

Historian Steam (1976) found

that despite the widely held medical belief that women decayed at
menopause, they were healthier and lived longer than men.

Surveys

conducted in the 1960s have shown that menopausal and post-menopausal
women have a more positive attitude toward this period than do
younger women, and do not consider it a significant event (Kraines,
1963; Levit, 1963; Neugarten, et al., 1968).

Contrary to psycho

analytic theory, Bart (1970) found that traditional, "feminine"
women experienced greater depression at menopause than did more
"liberated" women.

Cross-cultural studies strongly suggest that de

pression occurring at the menopause is related to cultural and
structural factors rather than psychological changes (Bart, 1969;
Dowty, 1972).

Dowty, et al., (1971) in a study of five sub-cultures

in Israel, found that although menopausal problems were related to
status changes, the women in the sample did not regret lost fertil
ity.
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All these studies suggest that women's subjective experience
has been ignored or at least de-emphasized. As McKinlay and
McKinlay state in their review of menopausal literature, "the power
of physicians ... has served to shield the knowledge and practices
of the medical profession, including the quality of research" and
"clinical experience has assumed unparalleled legitimacy as a basis
of knowledge and practice, regardless of its lack of objectivity and
substantiation" (1933).
Several historians have suggested that Victorian physicians
feared and envied women's sexuality and expressed their hostility
by inflicting painful and ineffective therapy.

Wood (1974) argues

that male physicians, acting in fear, were engaged in "psychological
warfare" and that medical practice was based on "veiled but aggres
sively hostile male sexuality and superiority".

Barker-Benfield

(1976) also focused on the psychological make-up of doctors.

Ac

cording to his thesis, drastic gynecological surgery and sadistic
treatment were the result of a tacit conspiracy between insecure hus
bands and anxious gynecologists, as a way of controlling women.
Yet to portray women as passive victims at the hands of sadis
tic doctors, as recent historical and feminist writers have done, is
to present an incomplete if not distorted picture.

Women and physi

cians are the products of the same cultural milieu, and share some of
the same assumptions and beliefs.

Psychological explanations might

be tempting, but ignore larger structural' factors.

Motives are

generally inaccessable to the social scientist, but placing whole
segments of past societies on the couch poses even more serious
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methodological problems.

As Verbrugge (1976) notes:

Sexual oppression has been a powerful factor in
medicine and society. But to see it as the primary
force oversimplifies history. Sexism and social
control are not intrinsic to medicine, but relate
to the socio-economic system at a particular time.
In that spirit, the remainder of this thesis is an attempt to
understand one controversial aspect of the menopause, Estrogen Re
placement Therapy, within a broad social context.

The chapter that

follows will examine how scientific, professional, political and
social movement factors have, and continue to, shape an important
medical practice.
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CHAPTER 3

THE ERT CONTROVERSY IN THE UNITED STATES AND GREAT B R ITA IN

In this chapter we demonstrate that the ERT controversy has de
veloped quite differently in the United States and Great Britain.
focus on four cross-cultural differences:

We

(1) the medical research

community, (2) physician practices, (3) feminist/consumer groups, and
(4) regulatory policy.

Before examining these differences we present

a brief overview of the medical controversy concerning ERT.

Medical Controversy

When did the controversy over estrogens begin?

While such an

assignation is arbitrary, it seems clear that the dispute is not a
new one.

A general association between estrogens and cancer has been

suspected since the 1890s (see Johnson, 1977).

Experimental animal

studies, conducted in the 1930s and 1940s, claimed that estrogenic
and progestinic substances were carcinogenic (Cook & Dodds, 1933;
Gardner, 1944; Perry & Ginzton, 1937).

In an article published in

the American Journal of Obstetrics and Gynecology, Novak and Yui
(1936) warned that estrogen therapy might cause a pathological build
up of endometrial tissue.
Most investigators trace the roots of the contemporary ERT con
troversy back to 1947.

In that year Dr. Saul Gusberg, then a young

cancer researcher at the Sloane Hospital and Columbia University in
New York, made the histologic link between hyperplasia (proliferation
of the cells lining the uterus) and adenocarcinoma in the human endo
42
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metrium.

After finding a significant increase of endometrial cancer

among estrogen users, Gusberg wrote in 1947:
Another human experiment has been set up in recent
years by the widespread administration of estrogens
to postmenopausal women. The relatively low cost
of stilbestrol and the ease of administration have
made its general use promiscuous.
Why was more attention not paid to these early warnings?

In ad

dition to the low cost and ease of administration of estrogens men
tioned by Gusberg, these early studies were judged to be scientifi
cally inadequate:

those based on animal studies were dismissed as

not applicable to humans.

Perhaps most importantly, though, estrogens

were seen as effective in treating vasomotor disturbances and vaginal
dryness and irritation, providing dramatic and immediate symptomatic
relief of even the most severe hot flashes.

This latter sentiment

was expressed in 1941 by Geist et al.:
...it is suggested that extreme caution be used
before attributing carcinogenic properties to
estrogen in human beings, lest an extremely val
uable therapeutic agent be condemned unjustly.
The current ERT controversy erupted in 1975 with the publication
of two independent epidemiological studies.

These and subsequent

studies concluded that women on ERT had a four to twenty times greater
risk of developing endometrial cancer than non-users.

Moreover the

risk of cancer increased with the duration and dose of estrogens
(for a review of eight such studies published between 1975 and 1979,
see Gusberg, 1980).

Indeed according to Gusberg, endometrial cancer

has apparently "superseded cervical cancer as the most common malig
nant tumor of the female reproductive tract" (1980, p. 729).
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The current medical controversy over ERT focuses on three ques
tions:

(1) is ERT a risk to health?

Strong claims have been made

that ERT significantly increases the risk of endometrial cancer.
Weaker but significant claims are also made that ERT, once thought
to protect against cardiovascular disease and breast cancer, ac
tually might increase the risk of those conditions.

Each and all

of these claims are disputed on a variety of clinical and methodo
logical grounds.

(2) What are the benefits of ERT?

Many research

ers claim that estrogens can prevent osteoporosis, the thinning and
weakening of bones associated with postmenopausal estrogen decline.
The extent of these claims is questioned:

some assert dramatic,

others only marginal, value of ERT in treating vasomotor instability
(hot flashes or flushes) and various vaginal and urinary tract prob
lems associated with the menopause.

ERT is also purported to alle

viate mental problems and act as a prophylactic against age related
changes in skin, hair and breasts; most current American research
dismisses these claims.
the purported risks?

(3) Are the purported benefits of ERT worth

Here, in a matter of urgent medical and public

policy, a judgment is necessary.

We will show' that, based on the

same scientific evidence, that judgment had developed quite dif
ferently in the United States and Great Britain.

U.S. and British Differences

The different actors and their positions are schematically pre
sented in Table 1.

Any classification scheme necessarily is sim-
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plistic and obscures individual case differences.

We do not imply

that groups are homogeneous in their endorsement or opposition to
ERT, only that the majority of literature examined points to pro or
con positions.
Table 1
ERT Positions Taken by Different
Groups in Each Country

Group

Researchers
Practitioners

cl

Feminists/Consumers

1)

Regulatory agencies

United States

Great Britain

Con

Pro

Pro

Con

Con

Pro

Con

Pro

Practitioner is the physician of first contact:
tain, usually a gynecologist in the U.S.

a GP in Great Bri

^The distinction between feminists and women consumers is not always
clear.

The remainder of this chapter is organized to explicate Table 1.
In turn we focus on each row of the Table.

First we examine the

American point of view; then we develop the British view by contrast.

The Researcher Community

In both countries researchers agree that risks as well as bene
fits are associated with ERT.

However, Americans have conducted re

search on the risks, whereas the British have concentrated on the
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benefits, of estrogen therapy.

American Researchers. In the U.S. the major focus of ERT re
search is now on the cancer linkage.

Since 1975 eleven American

studies have associated estrogen use with the development of endo
metrial c a n c e r . I n these retrospective studies, estrogen use of
patients with endometrial cancer was compared with that of matched
controls.

The women were of menopausal age or older and the estro

gens were of the type usually taken to relieve hot flashes and other
symptoms that accompany the cessation of the menses. The results of
these studies showed that significantly more of the cancer patients
had been estrogen users than of the controls.
The frequency of endometrial cancer in all postmenopausal, women
is 1 per 1000 per year; these studies report that for estrogen users
t

the frequency is about 4 to 20 per 1000 per year.

The first two of

these studies were published in the December 1975 issue of the pres
tigious New England Journal of Medicine.

Smith et al. (1975) found

that 152 of 317 patients with endometrial cancer had taken some kind.
of estrogen for at least 6 months.

Of the 317 controls, only 54 had

taken estrogens. The researchers concluded that estrogen users had
a 4.5 greater risk of developing endometrial cancer as compared to
nonusers.
At the Kaiser Permanente Medical Center in Los Angeles, Ziel and
Finkle (1975) compared the hospital records of 94 endometrial cancer
patients with 188 matched controls selected from the membership files
of the Southern California Kaiser Foundation Health plan.

The inves-
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tigators found that 57 percent of the cancer patients had used es
trogens, whereas only 15 percent of the controls had done so.

For

women who had used estrogens for one to five years, the risk of
developing cancer was 5.5 times greater than for nonusers.

Moreover

it was found that the risk increased with the duration of the treat
ment:

women who had used conjugated estrogens for seven years had a

15 times higher probability of developing the cancer.
Six months later the probability of a causal relationship be
tween estrogen and uterine cancer was strengthened with two more
reports published in the New England Journal of Medicine. The first,
a demographic study, noted that between 1969 and 1973 the incidence
of endometrial cancer had generally increased from 20 to 60 percent,
dependent on the geographical area surveyed.

The incidence was high

est among white middle-aged women belonging to the upper socio
economic strata (a ^0 to 150 percent increase)— the usual target po
pulation for ERT.

The magnitude of that increase, concluded these

researchers, "has rarely been paralleled in the history of cancer
reporting in this country" (Weiss et al., 1976, p. 1259).

This in

crease of endometrial cancer was found to be strongly correlated with
the temporal estrogen consumption among older women in the United
States.
The second study, conducted by Mack et al. (1976) on women at
an affluent retirement community, found that the odds of developing
endometrial cancer increased by. a factor of eight among estrogen
users.

Although the type of estrogen was not an important variable,

higher doses were found to increase the risk.

The authors concluded

R e p ro d u c e d with perm ission of th e copyright owner. Further reproduction prohibited without permission.

48

that the risk of developing endometrial cancer among estrogen users
is greater than the combined risk of breast, lung, ovary and colon
cancer.* *
Recent studies have differed

on whether the dose and duration

of estrogens are an important factor in the risk-benefit equation.
Even so the use of estrogens has been consistently related to in
creases in the likelihood of cancer.

Indeed in a review article

titled "The negative side of long-term postmenopausal estrogen
therapy," Ziel stated:
These [cancer] studies have been attacked on every
conceivable basis, but they have withstood the
criticism and the test of time. The association
of endometrial cancer with estrogen exposure is
nearly as strong as the association of lung cancer
with cigarette smoking. In fact the association
is so well established that no further research
grants are offered to study it (1980, p. 450).
OtherAmerican studies have also

asserted that ERT increases the risk

of breast cancer (Hoover et al., 1976; Ross et al., 1980), atheros
clerosis (Coronary Drug Project Research Group, 1973; Stadel & Weiss,
1975), myocardial infarction, pulmonary emboli, and thrombophle
bitis (Coronary Drug Project Research Group, 1970), hypertension
(Pfeffer et al., 1976), gall bladder disease (Boston Collaborative .
Drug Surveillance Program, 1974), and diabetes (Hammon et al., 1979).
At a 1979 Consensus Development Conference on Estrogen Use and
Postmenopausal Women— sponsored by the National Institute for Aging—
researchers unanimously concluded that ERT substantially increases
the risk of endometrial cancer.

The final report of the conference

recommended that ERT, if used at all, should be administered on a
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cyclical basis (three weeks of estrogen, one week off), at the lowest
dose for the shortest possible time.

Any candidate for postmenopausal

estrogen, it was recommended, "should be given as much information as
possible about both the benefits and risks and then, with her physi
cian, reach an individualized decision regarding whether to receive
estrogens" (Gastel et al., 1979).

British Researchers. British research is skeptical of the cancer
link, and instead has focused on the benefits of ERT.

For example

our analysis of the Consensus Development Conference bibliography
showed that nine British research studies were cited; all nine em
phasized the benefits of ERT.

At the Twentieth British Congress of

Obstetrics and Gynecology the consensus was to endorse the efficacy
of ERT and Cooper (1975) stated, "providing oestrogens are adminis
tered on a cyclical basis, most gynecologists today dismiss the can
cer link completely."
At a 1976 Menopausal Conference sponsored by the Royal Society
of Health, the efficacy of ERT was reaffirmed (this coming after
several American cancer studies), even for emotional problems.

"It

is well known," stated British endocrinologist Stuart Mason,
...that hot flushes can be relieved by oestrogen...
It is equally well known that the genital tract
atrophy which may be so troublesome a feature of
oestrogen deficiency is relieved by oestrogen.
Less well recognized are the aches and pains due
to connective.tissue changes induced by oestrogen
lack and the varied emotional disturbances that
may be related to oestrogen deficiency (Mason,

1976, p. 71)
In a

s im ila r

(Emphasis added).

vein, a recognized authority in endocrinology claimed
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that ERT was indicated for such problems as "depression, irritability,
anxiety, loss of energy, headaches, palpitations and absent mindedness" and should be used "before resorting to expensive and addictable tranquilizers" (Dalton, 1976, p. 75).

Another researcher

(Senior, 1976, p. 75) applauded the fact that British physicians were
finally recognizing the menopause for what it was— a deficiency dis
ease.
The participants at this conference also advocated the expansion
of NHS menopausal clinics (to be discussed in the "regulatory" sec
tion of this chapter)— specifically designed to promote estrogen
treatment.

But women should not wait for the universal establishment

of such clinics, for
...under the National Health Act it is the duty of
the general practitioner to give "reasonable and
necessary care"to those on his list. Who can deny
that hormone replacement therapy for those with
signs of oestrogen deficiency symptoms is "reasona
ble and necessary"? (Dalton, 1976, p. 77).
Perhaps the best way to summarize research opinion is to examine
the editorial positions of prestigious medical journals.

Here an

opinion or judgment, though written by an individual, carries the
imprimatur of the entire journal.

The editorial position of Lancet,

a prestigious British medical journal, has changed from a rather
cautious position in 1975 to a pro ERT one by 1977.

The first

editorial in 1975 acknowledged the efficacy of ERT to counteract the
most "insidious" hormone deficiency states such as osteoporosis
and "most importantly, the loss of femininity associated with pro
gressive atrophy of the secondary sexual characteristics", but
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warned of the unknown side-effects of long-term treatment.

It was

feared that "popular demand" for ERT would "overtake proper medical
caution" for
[ijn the van of the defence is a small but highly
vocal group of doctors and patients who claim
that long-term steroid replacement.is a woman's
right, and represent any contrary views as male
chauvinism (Lancet, 1975, p. 182).
Five months later, another Lancet editorial referring to the
American cancer studies stated:
Of the advantages [of ERT] there can be little
doubt— and some say that this therapy is a woman's
right. In contrast the disadvantages are nebulous
...(Lancet, 1975, p. 1135).
Finally a 1977 editorial criticized the methodology of the five Amer
ican cancer studies and judged the epidemiological evidence as "fra
gile":
The main objections to the five studies are: that
they were not double-blind and allocation to case
control groups was not randomized; that they were
not prospective; and that the groups were un
representative of the female population. Other
variables may have contributed to the association
— use of oestrogens for perimenopausal bleeding
caused by an unsuspected but pre-existing malign .
or pre-raalign lesion; greater frequency of diag
nostic examinations amongst hormone treated
women; and possible misinterpretation of oestro
gen induced hyperplasia as neoplasia (Lancet, 1977,
p. 577).12
The British Medical Journal found the American studies somewhat
more disquieting.

A 1976 editorial noted that since physicians have

been under considerable pressure to prescribe estrogens, many meno
pausal clinics have been established.

Therefore, a "possible causal

link" between estrogens and cancer "warrant careful examination."
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But the dilemna was resolved:
What should we do now? Smoking 20 cigarettes a
day increases the risk of death from lung cancer
17-fold. The risk of oestrogens is less than that.
In view of the positive benefits of oestrogen
therapy for postmenopausal women we are justified
in continuing to expose them to this risk (British
Medical Journal, 1976, p. 792).
This editorial was criticized by a prominent British researcher for

drawing "alarmist conclusions based upon so many suspect data".

He

continued that the "positive benefits of hormone replacement therapy
are now beyond dispute" and that:
It can be safely stated that there is no clinical
or epidemiological evidence that oestrogen in the
doses used to treat the climacteric syndrome are
in any way incriminated in the causation of endo
metrial carcinoma (Studd, 1976, p. 1145).
A 1977 British Medical Journal editorial criticized ERT as a
"fashionable" treatment and that short-duration treatment had been
abandoned in Britain because "long-term oestrogens have come into
vogue" (1977, p. 209).

The editorial then called attention to the

increasing number of American cancer studies.

•

This editorial drew an

angry response from the numerous British researchers who called the
editorial "misleading" and stated that ERT is "fashionable" only be
cause it is "effective" and that present evidence does not prove a
cause-and-effect relationship between estrogens and cancer (White
head et al., 1977, p. 453).

Another researcher stated that numerous

studies have failed to establish any association and it therefore was
unfortunate that an editorial would only state one side of the con
troversy:
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It is an unfortunate feature of the news media
in general that bad news seems to carry more weight
than good news, but this selective attention to
sensational positive reports at the expense of
less exciting negative results should not be allowed
to penetrate the scientific field (Nordin, 1977,
p. 454).
As several more American studies strengthened the purported can
cer link, British opposition shifted from methodological criticism to
criticism of the mode of therapy as practiced in the U.S.

It was

acknowledged that "unopposed" estrogens probably increased the can
cer risk, but that the addition of a sequential progestagen— the last
five to 13 days of a twenty to thirty-day course of estrogen— would
act as an anti-estrogenic agent and protect against endometrial hyperstimulation.

13

Thom has summarized these British claims:

The symptomatic and long term metabolic advantages
of oestrogen treatment should now be beyond dis
pute. ...There is no published evidence that lowdose cyclical oestrogen with progestagen is in
any way associated with an increased risk of endo
metrial hyperplasia or carcinoma (1979, p. 457).
John Studd, an insistent.and vocal ERT proponent, stated that
the increase in endometrial cancer in the U.S. is a measure of "bi
zarre therapy" rather than of dangers inherent in hormones, "a mis
take that would not be made by any final year medical student" (1979,
p. 922).

In a 1980 Interview Studd stated that the American ex

perience was the "result of inappropriate practice" and that the cur
rent belief of American physicians that estrogens cause cancer is to
be regretted since many women have severe menopausal problems, such
as "hot flushes and sweats" and have "terrible sexual problems, de
pression, irritability, shouting at the kids in the family and can't
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cope with feeling."

All these problems, according to Studd, can be

alleviated safely with combined estrogen-progestin therapy.

Another

researcher, drawing attention to British studies, stated:
If we are to avoid the incidence of endometrial
carcinoma currently reported in the United States,
we must surely adopt the conclusions of our own
studies and encourage the wider usage of proges
tagen - containing regimes of therapy for meno
pausal women (Sturdee, 1979, p. 1399).
The British argument has not been confined to the cancer issue.
Three recently published medical books are devoted to the benefits of
ERT (Beard, 1976; Campbell, 1977; Studd, 1977).

British research

has shown the efficacy of ERT for non-life threatening symptoms such
as flushes and sleeplessness, but has concentrated mainly on osteoporosis.
loss

14

These studies claim that ERT significantly retards bone

and may even prevent osteoporosis.

But once bone loss is star

ted, there is no evidence that estrogens can reverse the process.
Also if therapy is stopped, bone loss accelerates and returns to
base line in a short span of time.

The implications from these

studies are that for greatest effectiveness, ERT should be started
early, and once begun, continued to the end of the woman's life.
British researchers are advocating just that, but a 1980 British
Medical Journal editorial is somewhat more cautious:
The present evidence is still insufficient for a
final decision whether treatment with oestrogen
should be offered to all women from the time
of the menopause for the rest of their lives in
order to protect against osteoporosis. (Emphasis
added)

American Response to British Claims. Does combined therapy mini
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mize the cancer risk?

According to American researchers progestin

might reverse endometrial hyperplasia, but it is not yet well esta
blished that hyperplasia is a precursor of endometrial cancer (Stolley & Davis, 1979).

Furthermore, as was concluded at the Consensus

Development Conference (Gastel et al., 1979), the dangers associated
with progestin have not yet been fully evaluated, and the FDA has not
approved the combined treatment for menopausal use.

There is indica

tion that estrogen-progestin therapy is associated with hypertension,
heart disease, and diabetes (Hammond et al., 1979; Kase, 1980).

Some

American research also indicates that this combined sequential treat
ment did not prevent endometrial carcinoma:
The monthly addition of a progestin to a course of
estrogen did not prevent all endometrial cancers,
in young women taking the sequential contraceptives.
Postmenopausal women, who are at greater risk for
endometrial neoplasia, would have even less pro
tection (Ziel, 1980, p. 451).
Less serious, but a bother that older women often find unacceptable,
is that combined therapy causes monthly bleeding, mimicking the
menstrual cycle.
American researchers seem undecided about whether long-term
therapy can prevent or ameliorate osteoporosis. The Consensus Devel
opment Conference and the FDA state that estrogens are "probably"
effective if combined with calcium supplements and exercise but claim
that the cancer risk does not warrant long-term therapy.

Summarizing

the American position Ziel states:
The only potentially valid long-term use of
estrogen is for combating the development of
osteoporosis...Becker et al. have shown that as
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little as four 10 grain calcium carbonate tablets
daily stabilize bone density nearly as well as
0.625 mg of conjugated estrogen and 5 rag of
methyltestosterone taken daily. Perhaps, with
the addition of an exercise program or with pro
tein, fluoride, or Vitamin D supplements, bone
density would be equal or even exceed the density
achieved with estrogen (1980, p. 450).

Physician Practices

15

After weighing the research evidence, the patient's symptoms and
preferences, the physician decides whether or not to prescribe ERT.
Thus the physician of first contact becomes the crucial mediator be
tween the research community and the consumer.

In both countries,

the prevailing physician practice is in contradiction to the research
findings and to the demand of consumers.

American Physician Practices. In the United States the physician
of first contact is most often a gynecologist,particularly for
white, middle-class women, and appears to be quite willing to pre
scribe ERT.

That American physicians endorse ERT is shown by the

widespread use of the treatment.

Between 1963 and 1973 dollar sales'

for estrogen replacements quadrupled (U.S. Bureau of the Census,
1975).

Indeed, as one Harvard researcher stated, "few medical inter

ventions have had as widespread application as exogenous estrogen
treatment in postmenopausal women" (Weinstein, 1980).

By 1975, with

prescriptions at an all-time high of 26.7 million (Wolfe, 1979),
estrogens had become the fifth most frequently prescribed drug in the
country (Hoover et al., 1976).
According to population surveys in the 1970s, approximately one-
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third of the 30 million postmenopausal women were receiving estro
gens (Barrett-Connor, 1979).

The drug use varied by social class and

geographic area, with the highest use reported among middle-class
women living on the West Coast.

For example, a 1975 survey conducted

in the Seattle/Tacoma area revealed that 51 percent of postmenopausal
women had used estrogens for at least three months, with a median
duration of over 10 years (Weiss, et al. 1976).

Pfeffer (1977) found

that estrogen use continued into the seventh, eighth and even ninth
decades of life, and Barrett-Connor (1979) reports that 24 percent of wom^
en aged 70-74 were on ERT— this is in direct opposition to FDA and
research recommendations of "shortest possible use".

Even after the publication of the first three cancer studies in
1975, a spot check of gynecologists revealed that the new reports had
little effect on physician practices (Brody, 1975).

Each of the doc

tors interviewed pointed out that the studies did not conclusively
prove that estrogens cause cancer, and therefore no drastic change in
practice was warranted.

Brody quoted a San Francisco gynecologist:

I think of the menopause as a deficiency disease
like diabetes. Most women develop symptoms whether
they are aware of them or not, so I prescribe
estrogens for virtually all women for an indefinite
period.*7
Even though prescriptions for ERT have steadily declined since

1975, some 16 million were still written in 1978 (Wolfe, 1979).

In-

deed a recent survey showed that two-thirds of all women who saw

/
/

their physicians about menopausal complaints received estrogens and'

50 percent received tranquilizers (Dosey & Dosey, 1980).

In fact a

♦

1978 FDA drug analysis study concluded that menopausal estrogens, even
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after a major decline, were still "grossly overused" (Burke et al.,
1978).

Again in contradiction to FDA labeling, an analysis of 1979

estrogen replacement prescriptions revealed that a substantial por
tion (31 percent) were still written for such vague diagnostic cate
gories as "symptoms of senility", "special conditions without sickness", and "mental problems" (IMS, 1981).

18

19

*

Other measures of physicians' endorsement of ERT are authorita
tive references which describe menopause as a morbid condition for
which estrogen therapy is indicated.

For example, The Merck Manual

(Berkow, 1977; Holvey, 1972), a book of diagnosis and therapy widely
used by physicians, lists menopause under "Ovarian Dysfunction" and
Drugs of Choice (1980) lists it under "Diseases of the Endocine Sys
tem".

Both sources advocate estrogens for treatment, and Drugs of

Choice states in the 1980 edition that "objective studies" evaluating
the risks and benefits are "not currently available" (Modell, 1980,
p. 540).

Likewise, Current Medical Diagnosis and Treatment (Krupp,

1980) lists menopause under "Endocrine Disorders" and notes that
"estrogen therapy has been recommended for life" but "the advisability
of this practice remains unsettled" (1980, p. 731).
In its 1980 edition, Current Therapy claimed that the many symp
toms of the menopause "constitute the syndrome of estrogen deficien
cy" :
The philosophy underlying treatment should follow
the guidelines proposed for the other deficiency
diseases. There are parallels with hypoestrogenism,
hypothyroidism, and hypoinsulinism (Kantor, 1980,
p. 839).
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Under the risks and benefits of estrogen therapy, eight benefits are
listed including ’’improvement of disposition and unreasonable outburst
of temper" and "avoidance of the shrinking and sagging of breasts."
Attention is called to recent cancer claims but "when doses are small
and administration is in interrupted courses, any potential risk is
indeed small and perhaps theoretic."

But a patient who has been

frightened by "magazine articles" or "Food and Drug Administration
bulletins" may "psychologically block the benefits" of ERT (Kantor,
1980, p. 389).
Finally we note that physicians’ professional associations have
taken pro ERT positions.

The American Medical Association, the

American College of Obstetricians and Gynecologists, and the American
Society for Internal Medicine joined in a lawsuit (described later in
this chapter) to stop the FDA from warning consumers about the risks
of ERT.

Their affadavit claimed:
...that it interferes with the practice of medi
cine by physicians according to their best profes
sional judgment and by dictating the way in which
they may practice their prefession...The regula
tion will discourage patients from accepting es
trogen therapy when prescribed by doctors which
will impair the reputation of estrogens and reduce
the sale of the drug (quoted in Epstein, 1978, p.
236).

In another affadavit a Detroit gynecologist stated "The

b e st

[it]

will accomplish is a massive scare which the medical evidence indi
cates is wholly unwarranted" and the patient could experience such an
erosion of confidence
...that she would not bother contacting her doc
tor at all, but simply discontinue consultation
with the physician in the mistaken belief that he
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lacks competence or adequate concern for
her
(quoted in Grossman & Bart, 1979, p. 167).
Speaking for the AMA, William Barclay feared that patients, upon read
ing the warning, "will develop symptoms through suggestibility and
will blame the physician and the medication for problems that are
really caused by the [warning]" (1980, pp. 95-96).
The official journal of the American Medical Association, in

20

contrast to the research oriented New England Journal of Medicine,

has as recently as 1979 and 1980 endorsed long-term estrogen therapy
andseverely criticized the FDA for regulating

ERT products. In

a

"special communication" the Journal noted that thebenefits of ERT
outweigh the risks and reprimanded the FDA Commissioner for mandating
a "biased" warning:

"In doing so he has officially expressed his

distrust of the medical profession.

He has also committed himself to

a slanted, if not dishonest, presentation of the facts" (Landau, 1979,
p. 47).

In the 1980 American Medical Association Journal editorial

the FDA was again criticized for creating unnecessary "public anxie
ty" since "Estrogens already rank among the safest of all pharma
ceuticals" (Meier et al., 1980, p. 1658).
The tenacity of American gynecologists in maintaining the use of
estrogen therapy is evidenced by the publication of a new popular
book titled A Woman Talks with Her Doctor:
Womens* Health Care (Flowers, 1981).

A Comprehensive Guide to

The author, a "practicing

gynecologist for nearly thirty years" states
My personal position is that long-term estrogen
replacement may be appropriate and beneficial
for many patients and it certainly can be safe
when used under a doctor's care .... It is dis-
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tressing to me to think.of a number of women in
our country,.who are developing painful inter
course or having unnecessary.bone fractures from
osteoporosis because they have been frightened
away from estrogen therapy by the exaggerated
dangers described in package inserts (Flowers,
1981, pp. 246-247).

British Physician Practices. The National Health Service (NHS),
instituted in Great Britain in 1948, took great care to preserve the
general practioner (GP) as the physician to provide first contact and
also long-term care.

Indeed, it has been estimated that the GP is the

only point of contact for 90 percent of all persons seeking medical
help (Sidel & Sidel, 1977).

Only patients with major or complex ill

nesses are referred to a specialist (known as a consultant) at a
clinic or hospital.

21

Numerous secondary sources indicate the GP's reluctance to pre
scribe ERT.

The best known is British feminist and journalist Wendy

Cooper who stated that she has received over 5000 letters from women
complaining that their GPs refused to prescribe hormone treatment.
Though "more and more top British gynecologists are coming out in
open support," she lamented that "...at the family-doctor level there
is still considerable resistance based on either apathy or ignorance"
(1975, p. 20).

It is one thing to prove that ERT works, noted

Cooper, but quite another to get the traditional minded GP to "accept
the revolutionary idea of the menopause as a deficiency condition
that needed treatment":
After all, over the centuries the "change" had been
considered a natural and inevitable part of aging,
a normal state for a woman at a certain time of
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life (Cooper, 1975, p. 18)
Similarly Evans, a physician herself, stated:

British doctors have undeniably been, and many
still are, slow to accept the wider use of hormone
treatment at the climacteric. If they thought
about it at all, the last generation of doctors
was likely to regard the menopause as something
women had to get on with (1979, p. 99).
Evans feels that general practitioners are not well informed about
the climacteric and many do not feel "equipped for the routine manage
ment of menopausal problems, and have neither the time or inclination
to become closely involved" (1978, p. 100).
To circumvent the GP's reluctance to prescribe ERT, NHS meno
pausal clinics, usually attached to research hospitals, were esta
blished beginning in 1973.
Women's Health Care, Ltd.

22

Additionally, an organization called
was established with the sole purpose of

providing information on menopause and to make available lists of
gynecologists and menopausal clinics specializing in ERT (Gillie,

1975).
It appears that the continued demand for ERT (this demand is do-,
cumented in the next section) has had an effect on physician prac
tices.

An analysis of British prescription data (in contrast to

American ERT prescriptions which have declined 40 percent since 1975)
revealed that between 1971 and 1977 the number of ERT prescriptions
increased roughly threefold to about 1.2 million (Bungay et al.,
1980).

Since this figure includes both new and refill prescriptions,

it is difficult to establish the actual number of women on ERT.

The

pharmaceutical industry estimated that in 1973 some 50,000 UK women
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were receiving ERT whereas by 1978 that figure was nearer to 200,000
(Bye, 1978; Evans, 1979).

A 1979 London Times (Edmunds, 1979) arti

cle claimed that about 500,000 women were receiving ERT; and a survey
of 40,000 people in a general practice population found that 3 percent
of women aged 40 to 79 had received at least one ERT prescription
during the year (Doll, 1976).
In Great Britain there are some 10 million women aged 45 and ol
der (United Nations, 1978).

Whether the actual number of women on ERT

is 200,000 or 500,000— from 2 percent to 5 percent of the population
at risk— it is still considerably less than the 20 percent (6 to 7
million) of American women in that age bracket who are currently
receiving estrogens.

Even with a more than three-fold increase in

estrogen prescriptions— an increase which "place them in the fastest
growing section of the pharmaceutical industry"— British women, ac
cording to Evans, are still under-treated since only about "a fifth
of those who need treatment receive it" (1979, p. 132).
A final discrepancy between research recommendations and physi
cian practice can be noted in the prevailing mode of ERT therapy.
British researchers have been highly vocal in their criticism of
"cyclical" therapy (three weeks of estrogens, one week off) as
practiced in the United States and have advocated "sequential" thera
py with an added progestagen to avoid the endometrial cancer risk.
Ironically, an analysis of British prescriptions revealed that only
about 6 to 10 percent of ERT prescriptions contained the added
progestagen (Bye, 1978; Thom, et al., 1979).
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Feminist and Consumer Groups

In both countries feminist and consumer groups (the two relevant
types of voluntary associations) view the menopause differently and
take a different stance toward ERT.

American Feminists and Consumer Groups.

In the late 1960s and

early 1970s feminists began to challenge medical authority by ques
tioning the legitimacy of the disease model of menopause.

They have

argued that menopause is not a disease or sickness but a natural
process of aging, through which most women pass with minimum diffi
culty.

The.medical problems that do arise can be effectively treated

or even prevented by adequate nutrition and exercise combined with
vitamin supplements.

According to feminists, the menstrual and meno

pausal myths serve as a form of social control.

If women are per

ceived as physically and emotionally handicapped by menstruation and
menopause, they cannot and may not compete with men.

The medical

health care system is seen as legitimating, under the guise of
science, societal sexism through its depiction of women's physical
and mental capabilities dependent on their reproductive organs.
On these ideological grounds, feminists have opposed the routine
use of ERT.

For example, a 1972 M s . article, written before strong

medical evidence against ERT was uncovered, maintained that menopause
was not a traumatic experience for most women, but rather a sexually
liberating one.

ERT as an attempt to keep women "feminine forever",

was thus viewed as a male exploitation of female sexuality (Solomon,
1972).

In a feminist interpretation of the menstrual and menopausal
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taboo, Delaney, et al. (1976, p. 184) state that "the main fault of
Feminine Forever lies not in the medicine but in the moralizing".
In more recent years, with ideological arguments strengthened
by medical ones, feminist criticism has become widespread.

In Women

and the Crisis in Sex Hormones (Seaman & Seaman, 1977) the ERT con
troversy receives a 70-page analysis titled "Promise Her Anything But
Give Her ... Cancer".

These authors object to what they see as the

increasing medicalization of normal female functions:
Pregnancy or non-pregnancy are hardly diseases; and
neither is menopause. The latter is a normal de
velopmental state wherein reproductive capacity is
winding down; the temporary hot flashes some women
experience may be compared to the high-to-low voice
register changes adolescent boys evidence when
their reproductive capacity is gearing up.
We no longer castrate young boys, nor should we
treat hot flashes with a cancer-and-cholesterol
pill (1977, p. xi).
In a collection of feminist critiques (Hubbard et al., 1979), two
social scientists make a similar claim in a chapter entitled "Taking
Men Out Of Menopause":
...[the] actions of the medical and pharmaceutical
groups dramatize the sexism and general inhumanity
of the male dominated, profit oriented.U.S. medical
system. A "deficiency disease" was invented
to serve a drug that could "cure" it, despite the
suspicion that the drug caused cancer in women.
That the suspicion has been voiced for so many
years before anyone would investigate it is yet
another example of how unimportant the well-being
of women is to men who control research and drug
companies who fund much of it (Grossman & Bart,
1979, p. 167).
The 1981 edition of The Ms Guide to a Woman’s Health warns women
that "Estrogen replacement therapy (ERT) is a dangerously overused

R e p ro d u c e d with perm ission of th e copyright owner. Further reproduction prohibited without permission.

66
treatment.
310).

Avoid it if at all possible" (Cooke & Dworkin, 1981* p.

The chapter on menopause repeatedly states that the change of

life is not a disease but a normal process.

Similarly, The New

Woman's Guide to Health and Medicine states "The truth is that meno
pause is a positive or at least neutral experience for many women"
(Derbyshire, 1980, p. 269).

Several other publications, such as

Ma.jority Report and Off Our Backs, have taken strong stances against
ERT.

And the leftist publication, Mother Jones, condemned ERT in an

article entitled "Feminine Straight to the Grave" (Wolf, 1978).
Though most of the criticism has been voiced by younger feminists,
some older women have also begun to join the opposition.

In Menopause:

A Positive Approach, Rosetta Reitz refers to ERT as "The No. 1 Middle
Age Con":
I accept that I'm a healthy woman whose body is
changing. No matter how many articles and books I
read that tell me I'm suffering from a deficiency
disease, I say I don't believe it. I have never
felt more in control of my life than I do now and I
feel neither deficient nor diseased. I think that
people who are promoting this idea— that something
is wrong with me because I am 50— have something to
gain or are irresponsible or stupid (1977, p. 181).
Marjorie Collins in an article in Prime Time, a publication de
voted to ageist issues, stated:

Even today the literature...defines menopause as a
deficiency disease. Of course that may sell, estro
gen, and we'll stay out of the controversy over
whether that's a good thing or not. But it certain
ly echoes once more the male prejudice against meno
pausal and post-menopausal women (1977, p. 3).
Health related associations and consumer
feminists in their opposition to ERT.

g ro u p s

have also joined

Consumer Report (1976), the
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official publication of Consumers Union, published a lengthy article
warning women of the risks; and Citizens Health, the Nader organiza
tion, opposes (and regularly testifies against) ERT.

Smaller groups

such as WHISTLE (Womenfs Hormone Information Service), Coalition
For the Medical Rights of Women, and National Action Forum for Older
Women, have all warned women of the risks of ERT and advocated al
ternative menopausal treatments.

Menopause workshops and self-help

groups have sprung up across the country.

On the national level,

the National Women’s Health Network has actively opposed ERT and in
their 1980 Menopause Resource Guide, they urge women to stay away
from ERT and flatly state that estrogens do not protect against
osteoporosis (National Women's Health Network, 1980, p. 17).
After the 1975 cancer studies, these organized feminist health
and consumer groups began to put pressure on the government to le
gitimize their claims.

These activities will be discussed in more

detail in the last section of this chapter when we examine regulatory
policy.
British Feminists and Consumer Groups. British feminists and
consumer groups have strongly endorsed ERT.

They argue that estro

gens are a woman's right and that male chauvanism makes physicians
insensitive to women's health and pain.

Whereas the U.S. crusade for

ERT took place in the 1960s, the message did not arrive in Britain
until the 1970s.

Also in contrast to the American experience, where

the ERT movement was led by prominent gynecologists, in Britain the
treatment was demanded by women consumers.
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Wendy Cooper, a feminist journalist and medical writer, is

generally credited for the popular acceptance of ERT in Great Britain.
As one British physician stated:
Thanks to the enthusiasm of crusading journalists
like Wendy Cooper, many doctors in Britain and
their patients began to realize for the first time
the benefits of [hormone] treatment (Evans, 1979,
p. 13).
Cooper documented the struggle to overcome physician resistance to
ERT in her widely cited book Don’t Change (1975).

She admonishes

women to be firm with uncooperative doctors since "We are having the
menopause" therefore "we shall have hormone replacement":
Indeed, the real problem facing women today in con
nection with ERT reflects the basic problem facing
them in every sphere of life— the problem of how
to enforce their equal rights, including the right
to make their own vital decisions, particularly
decisions concerning their own bodies (1975, p.
131).
With the availability of estrogens, women now were seen to have
a choice:

they no longer needed to be "fobbed off during the meno

pause with palliatives such as aspirin, Librium or Valium, or worse
still, be dismissed with the words:

It’s just your age" (1975, pp.

12-13).
Although Cooper appears to be heavily influenced by the works of
Robert Wilson (whom she personally interviewed), she is critical of

his emphasis on femininity:
Writing as a women for other women and also writing
almost a decade later in the age of Women's Libera
tion, I have put less emphasis on femininity and.
more on feminism and on the right of women to have
more say in decisions, medical and social, which af
fect their own bodies and their own lives (1975, p,

20).
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To spread her message, Cooper has appeared on numerous radio and
television programs, and has written extensively in both the medical
and lay press.

That a segment of the medical community has taken her

seriously is evidenced by her numerous articles appearing in the
medical literature.

For example, she has published in Current Medical

Research and Opinion (1975), World Medicine (1976), the Royal Society
of Health Journal (1976) and has original chapters in two recent
medical books on menopause (Beard, 1976; Campbell, 1976).
Cooper was soon Joined by other feminists and consumers.

An

analysis of the London Times and British medical journals reveals
that the feminist demand for the therapy is widely acknowledged.

For

example, one physician credits feminists for the "medical profes
sion's belated interest" in ERT but cautiously continues "It is hoped
that the proper clinical interest does not lead us into the trap of
creating a fashionable specialty if that trend is motivated merely by
feminist politics (Tunnadine, 1977).
Barbara Evans, a well known woman physician and author of the
recent pro ERT book Life Change, acknowledged Wendy Cooper and her
feminist sisters:
We owe a great debt to the women who have written
and canvassed so energetically to bring the needs
of women and the help that is available not only
into public but also into medical consciousness
(1979, p. 95).
Evans continues that male physicians are often ignorant of female
sexuality and physiology and therefore the "more enthusiastic advo
cates of hormone therapy have often been women doctors, especially
those who have personal experience with the climacteric" (1979, p. 98).
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Ironically, "as British women are demanding oestrogen therapy
their American sisters are becoming reluctant to take the implied
risk" (Evans, 1979, p. 10).

In direct opposition to American femi

nists' claims, British feminists insist that the menopause is not a
natural process but a hormone deficiency disease.

Writing in 1979

Evans noted that a large number of British women are still denied ERT.
She found this particularly regrettable, since, as noted in the fore
word to her book:
The years after the menopause should be regarded
as a hormone-deficient state, in the same way as
diabetes. The hormone insulin is usually required
for the treatment of diabetes and the fact that
insulin has side effects and such therapy may not
correct all the hazards of the disease in no way
alters the truth of this definition (1979, p. 10).
Cooper called the "natural process" model an excuse for "benign
neglect" and carried to its logical conclusion would imply that other
"natural" aging processes such as failing eyesight, impaired hearing,
decaying teeth and arthritis should not be treated either (1976, p.
81).

Cooper has eloquently summarized the British feminist argument:
With the short-term advantages so clearly obvious
and the long-term protective role so strongly in
dicated, women are entitled to ask why medicine
has been so reluctant to accept HRT?....If it were
men who faced menopause with atrophy of their sex
organs, the male dominated medical profession would
long since have done something about it. There would
certainly be far less talk about its being natural
and needing no treatment (1975, pp. 51, 62).
In contrast to the U.S., most pro ERT feminists have been middle

aged women.

A young radical feminist group, the Brighton Women and

Science Group, has shown considerable ambiguity toward ERT and the
menopause.^

In Alice Through the Microscope, a book devoted to
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women's health issues, they indict the medical profession for perpe
tuating the menstrual and menopausal taboo.

At the same time they

view menopause as a difficult time for most women.

They also acknow

ledge the benefit of ERT but note "too much enthusiasm about the
wonders of ERT is permature.

Quite simply, there has not been enough

research to indicate whether taking drugs for long periods of time
might be hazardous to health" (Birke & Best, 1980).

They conclude

their brief, three-page section on menopause with considerable am
bivalence :
As we write this, we are still young, still menstru
ating. One day, we will go through the menopause
just as our mothers are doing now. We hope that we
cope with it as well as they do (Birke & Best, 1980).
Health groups in Great Britain also appear to endorse ERT.

In

the February 1980 issue of Patient Voice, a publication of the Pa
tients' Association (devoted to promoting patients' rights), the
therapy is strongly endorsed, the cancer link is disclaimed and it is
maintained that estrogen replacements effectively treat such symptoms
as absent-mindedness, forgetfulness and depression as well as hot
flashes and osteoporosis.

In this same issue, the question is posed

why doctors still dismiss symptoms of the menopause as being "all in
the mind" and prescribe anti-depressant drugs when "oestrogen supple
ments can produce complete remission".

Readers are also made aware

of a newly organized "Steroid Self-Help Group" and urged to write for
details.

Regulatory Policy

25
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As in other public realms, regulatory policies in the United
States and Great Britain have differed sharply in response to the es
trogen replacement controversy.

American Regulatory Policy.

In the U.S. the Food and Drug Ad

ministration (FDA) has placed increasingly stringent regulations on
menopausal estrogens.

In January, 1976, at the conclusion of a high

ly publicized Senate Subcommittee hearing, the FDA released a public
statement citing evidence of a strong positive association between
estrogen use and endometrial cancer (Burke et al., 1977).

26

The

March, 1976 issue of the FDA Bulletin, a bi-monthly publication sent
to all health professionals, emphasized the limited utility and short
term low dose indications of ERT.

It recommended that the risks be

carefully considered by both physicians and patients.

In the fall

of 1976 the FDA revised and strengthened the physician package in
sert which accompanies all bulk packages of estrogens distributed to
pharmacies and physicians.
After the 1975 cancer studies several consumer and feminist
groups, including the National Women's Health Network and Consumers
Union, began to exert pressure on the FDA to warn the consumer of the
dangers of ERT.

In 1977, after two years of public hearings, the

FDA mandated that a "patient package insert" (PPI), warning consumers
of the cancer risk and other possible dangers, be included with every
estrogen and progestin prescription (New York Times, 1977).
In an effort to block this regulation, the Pharmaceutical Manu
facturing Association— joined by the American College of Obstetricians
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and Gynecologists, the National Association of Chain Drug Stores,
the American Society of Internal Medicine, and various state and
county medical societies— responded by filing a law suit against the
FDA.

To represent the interests of women patients, the National

Women's Health Network, Consumers Union, Consumers Federation of
America, and Women’s Equity Action League, intervened in the law suit
on behalf of the FDA.
On 5 October 1977 a Federal District Court judge denied the
plaintiffs' motion for a preliminary injunction; and on 11 February
1980, after a lengthy legal challenge, this judge ruled that the FDA
did have the legal authority to mandate a PPI for estrogen replace
ments (Stapleton, 1980).
The ruling gave estrogen replacements the distinction of being
one of only four classes of drugs which require such patient package
inserts.

27

The judge outlined several categories of information which

must be included in the PPI.

In addition to an increased risk of

uterine cancer, increased risks of breast and liver cancer and in
creased risks of cardio-vascular and thrombo-embolic diseases were
also required to be mentioned.

This information was to be provided

to the patient every time the drug was dispensed or administered
(i.e., injected).

28

Thus physicians and hospital personnel as well as

pharmacists were required to provide the labeling when they act as
dispensers of the medication (Stapleton, 1980).
Regulation, however, does not mean compliance and the victory
for ERT opponents appears to be more symbolic than instrumental.

A

recent FDA survey of 271 drug stores in 20 cities showed that only 39
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percent of all estrogen replacement prescriptions were accompanied
by a PPI (Morris et al, 1980).

29

In an interview with us, an FDA

official stated that the agency did not have the means to enforce
these regulations (Morris, 1980).

British Regulatory Policy.

From the British point of view,

drug regulation in the U.S. leads to "inflexibility", "rigidity",

"polarization", and "irrationality", (Breckon, 1972; Dunlop, 1973;
Gillespie, 1980).

An "informal" and "friendly" approach is seen

as more palatable to the "British character".

Indeed no government

agency overseeing drug safety even existed until 1964, when the Committee on the Safety of Medicines (CSM) was formed.

30

This Committee

acted solely as a voluntary advisory body with no legislative powers.
Although the 1968 Medicines Act, implemented in 1971,

31

gave the

Committee statuatory power, it still operates on a relatively in
formal basis.
The CSM does no official drug testing, but relies on the phar
maceutical manufacturers to carry out their own drug safety tests.
The Committee reviews and comments on the industry findings, but the
commercial concerns themselves are responsible for, and trusted to
make, judgments on safety standards (Breckon, 1972).

32

"The Committee

is always ready to listen to manufacturers or trade associations,"
stated one member, "and tries hard to be fair."

The Committee is

also
concerned with maintaining and improving standards,

....but is emphatically not concerned with restrict
ing doctors' freedom or otherwise control their use
of drugs (Binn, 1980, p. 1615).
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Operating in that spirit, it is not surprising that the CSM
has issued a statement exonerating both estrogens and progestins
from any causal relationship with cancer (Cooper, 1975, 1976).

33

British regulatory efforts, by American standards, have been
quite timid.

However the British National Health Service (NHS) has

adopted an innovative program on menopausal treatment.

In response

to the researchers' endorsement of ERT and a burgeoning public demand
for the treatment, the NHS, in 1973, began operating menopausal
clinics.

These clinics, designed to circumvent the GP's reluctance

to prescribe ERT, also serve as centers for research and evaluation
of the treatment.
The first clinics were deemed highly successful and "filled with
strikingly happy patients (Evans, 1979, p. 101).

But demand quickly

exceeded available service and clinics soon had to contend with long
waiting lists.

At a 1976 Royal Society of Health menopausal confer

ence, the participating researchers reaffirmed the value of ERT and
advocated the expansion of NHS menopausal clinics.
Gradually more menopausal clinics are being es
tablished and regular examinations are instituted,
and hormone replacement is undertaken. The op
timist hope that as more financial help becomes
available within the National Health Services,
more clinics will be established (Dalton, 1976,
p. 77).
By 1979 about forty NHS and an additional 17 private menopausal
clinics had been established across the Kingdom.

The NHS clinics are

attached to major research and teaching hsopitals and provide "ser
vice-oriented research" (Evans, 1979).

Since only an estimated one-

fifth of menopausal women who are seen to need treatment actually

76
receive it, the expansion of clinics appears likely (Evans, 1979).

Summary

Though medical objections to estrogen treatment for menopausal
problems have been voiced for several decades, the current controversy
arose in 1975 with the publication of three epidemiological studies
linking ERT to cancer.

The controversy, however, has developed quite

differently in the United States and Great Britain.

Most U.S. re

searchers accept the endometrial cancer link and are cautious in
recommending estrogen therapy; their British counterparts, on the
other hand, are skeptical of the cancer link and recommend long-term
treatment for the prevention of osteoporosis.

Despite U.S. research

findings, American physicians, still commonly prescribe ERT; British
physicians, in opposition to their research community, are reluctant
to prescribe the treatment.

Whereas American feminists and consumer

activists have opposed the use of ERT, these same groups in Britain
have demanded estrogen therapy.

Finally regulatory policy has dif

fered in the two countries: the FDA has imposed increasingly stringent
regulations on ERT, whereas the CSM has not moved to restrict the
treatment.
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CHAPTER IV

DISCUSSION

In the previous chapter we delineated differences in the estrogen
replacement controversy in the United States and Great Britain.

For

each row of Table 1— researchers, physicians, feminists/consumers,
and regulatory policy— we found, and documented, variance between the
two countries.

For each column in Table 1 we noted that feminist and

consumer groups are in opposition to prevailing physician practices;
clinical practice, in turn, is in opposition to research conclusions
in each country.

Thus the U.S. and Great Britain appear in mirror

image with regard to ERT:

group alignment is identical; direction is

opposite.
The purpose of this chapter is twofold.

First we attempt to ex

plain some of the cross-cultural differences and similarities by
focusing on scientific, ideological, political and economic factors.
Second we relate our findings to some current theoretical debates in
sociology in a speculative way that is intended to raise, rather than
answer, questions.

Cross-Cultural Similarities and Differences

That scientific experts disagree and oppose each other's view is
hardly a novel finding.

Considerable discussion has been devoted to

this topic in the sociology of knowledge literature.

In an analysis

of scientific and technical controversies, Mazur (1981) found that
ambiguity of data was always an underlying condition of controversy.
Ambiguities lead to different interpretations, and consequently
77
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experts talk past one another.

Using similar rhetorical devices,

each expert tends to reject the other’s data as discrepant.

Dif

ferences in underlying definitions and in basic premises thus become
obscured or ignored as both sides present their findings as "definite
facts."
There is no conclusive evidence that ERT causes cancer, as most
American researchers contend, or that it prevents osteoporosis, as
most of their British counterparts claim.

Mazur (1981) also noted

that group alignment in scientific disputes is often based on situa
tional rather than objective factors.

Alignment often comes first,

and only then does the new partisan construct a rationale for the
alignment.

In many cases alignment serves as an anchor point around

which the various findings are interpreted.

As Mulkay stated:

We have seen that scientific fact depends on
prior commitments of various kinds, that these
commitments are often made in accordance with
participants' position in a special social set
ting, and they influence the informal acts of
interpretation which are essential to give meaning
to observations (1979, p. 114)
For whatever reasons, British researchers first conducted re
search on the role of estrogens in osteoporosis, whereas American
researchers conducted the cancer studies.

Both sides have clung to

their initial findings and are skeptical of the other country’s findings.

34

Researchers on both sides of the ERT controversy have ac

cused the other side of this bias as the following letter to the
editor in Lancet demonstrates:
For a scientist to pretend that his observations
are unprejudiced is a fiction that underlies what
Medawar called the fraudulent form of the tradi
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tional scientific paper. He said "Every act of
observation we make is biased. What we see or
otherwise sense is a function of what we have
seen or sensed in the past." Your editorial is...
guilty of that observation (Greenblatt and Gambrell,
1979).
It is also evident that British and American researchers have
different assumptions about what constitutes carcinogenicity.

Marvin

Schneiderman, former Associate Director of the National Cancer Insti
tute, noted in a letter to us:
Recent British work on
more conservative than
be much more reluctant
to assert cause-effeet

carcinogenesis seems much
ours in that they seem to
than American researchers
relationships (1980).

Similarly Gillespie et al. (1979) have shown that the British demand
evidence of causality before a substance is judged carcinogenic; in
the U.S. a demonstrated risk, as determined by scientific consensus,
is sufficient.

A persistent British criticism has been that retro

spective epidemiological studies, using historical controls, cannot
prove a cause and effect relationship between estrogens and cancer.
Only double-blind, randomly assigned prospective studies, conducted
over a span of several decades, can establish the carcinogenicity of
estrogens.

To summarize the British position:
Until specific answers are forthcoming we can
keep an open mind on the subject. In the in
terim it is not justifiable to withhold such
therapy from the informed patient requesting it
(Utian, 1977).

American researchers argue that causality can be deemed likely if
the risks uncovered are high, replicable, consistent, show relation
ship between dose and duration of exposure and are biologically
plausible.

The American cancer studies seem to meet these criteria.
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Thus it is argued that randomized controlled trials are no longer
ethically feasible.

35

It is often pointed out that the smoking-lung

cancer debate was settled (at least in the U.S.) without randomized
trials:
There has never been a randomized controlled trial
(similar to that which they [the British] demanded
for estrogens) to determine if cigarette smoking
causes lung cancer in human beings; do these phy
sicians withhold judgment forever while awaiting
the impossible study, or do they advise patients
to stop smoking? (Stolley & Davies, 1980).
One reason for the British scientists' more rigorous (or conser
vative) standards in deciding carcinogenicity of a substance

might

be that fear of cancer is heightened in America as compared with
Great Britain.

Gillespie et al. (1980) noted that fear of cancer

does not carry the same political weight in Great Britain, especially
in policy circles.

That Americans are "cancerophobic" has been shown

by repeated public opinion polls, in which the killing potential of
cancer is vastly over-rated (Gallup, 1977).

Susan Sontag (1978) also

contended that cancer is highly stigmatized in American society.

36

In both countries current policy is consistent with research
findings and consumer demand, but inherent political factors might
also be important in determining cross-cultural differences.

Despite

a greater socialistic tradition the British medical and scientific
communities appear to be more elitist and resist government interference to a greater degree.

37

According to the first chairperson of

the CSM, a formal and compulsory system like the FDA would never work
in Britain.

Such a system would be unacceptable, he said, to the

medical profession which prefers decisions to be taken by scientists
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and physicians who are not dependent for their income and reputation
on government bureaucracies (quoted in Breckon, 1972).

38

Some scholars posit an economic explanation for the stricter
American regulation.

They argue that since the U.S. has a much wealth

ier economy than Great Britain, its pharmaceutical industry is suffi
ciently robust to absorb the costs of closer scrutiny (see Breckon,
1972, Gillespie et al., 1979).
In both countries, the feminist-physician dispute-seen as a con
sumer challenge to professional authority— is largely ideological.

In

his seminal work on professionals, Hughes (1958) pointed out that
professional authority is inherently problematic and open to challenge.
Clients do not automatically grant authority and autonomy to profes
sionals.

Rather authority is the result of professional enterprise.

Professionals who serve clients can maintain their authority when
it becomes institutionalized in ways that minimize reliance on ex
planation or persuasion (Freidson, 1968).

In recent years clients—

particularly from subordinate or subjugated groups such as women,
minorities, homosexuals, etc.— have begun to challenge professional
authority.

It has even been suggested that conflicts between clients

and professionals represent the new dialectic.

For as labor shifts

from industrial production to services, control over this segment
of the economy becomes increasingly important (Bell, 1978; Freidson,
1973; Gartner & Riessman, 1974).
In the United States as well as in Great Britain, feminists are
becoming more militant in demanding control over their own bodies
and a voice in medical decisions which affect their own lives.
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one British feminist declared:
... for the last couple of thousand years, it has been
men of the ruling class...doctors mainly concerned
with their own power and prestige, who have created
laws, laying down to women what they may ormay
not do with their bodies (Wandor, 1972).
In both countries the male dominated medical profession is coming un
der increasing criticism for defining women's psychological, as well
as their physiological reality.

The authority and competence of the

medical profession is being challenged as women attempt to redefine
the prevailing medical definitions of menopause.

In Britain women con

tend

that the menopause is a hormone deficiency disease, and do not

want

tobe told that it is "all in their heads" or be put on anti

depressant drugs.
on demand.

ERT is seen as a woman's right and should be given

But as one British feminist decried:
Unfortunately, many women still stand in such awe
of their doctor.... that if he refuses to prescribe
HRT, they give up the fight, accepting this one
verdict as law. Indeed, although the trend is de
finitely toward wider usage of HRT as the indicated
treatment for the menopause, the divergence of
views is confusing to women nourishing the naive
belief that modern medicine is a science (Cooper,
1975, p. 83).

In the U.S., feminists are trying to counter the prevailing medical
definition of menopause as a disease by claiming that it is a natural
occurrence in the process of aging; proper nutrition and exercise, it
is claimed, will alleviate most transitory symptoms.

As these self-

declared radical feminists contend:
This redefinition of a natural event such as meno
pause into a disease is an example of the increasing
medicalization of normal events in our lives....
This process is both a cause and effect of the enor
mous power American physicians have to define and
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manipulate our reality (Grossman & Bart, 1979,
p. 165).
It would be simplistic to characterize the British claim of
menopause as a disease, and the American feminists' claim of a
natural stage of aging, solely as an arbitrary challenge to profes
sional authority and a wish to control their own bodies.
also indicate a demographic variable:

The data

American opposition to ERT

has been mainly by feminists who are still young and menstruating;
the pro ERT British crusade has been led by older feminists.

39

The

actual experience of menopause and the reality of aging might be con
ducive to viewing ERT as a viable treatment.

It has also been sug

gested that psychoactive drugs (the most common treatment for meno
pausal problems available from British GPs) are particularly repug
nant to British women.

With the British tradition of "keeping a

stiff upper lip", the reliance on tranquilizers might carry a greater cultural stigma than would a drug for a somatic problem.

40

The American and British women's movements have also developed
along different ideological and political lines which might explain
some of the variance in ERT positions.

The American movement is best

described as "free floating", not aligned with any particular political or class movement.

41

Although the movement is comprised of many

different factions, neither the liberal (as typified by NOW) nor
the more radical groups have seriously challenged the politicaleconomic system.

Whereas the older NOW members have advocated liberal

reformism and have lobbied for their equal place in the economic
sphere, the younger radical groups have concentrated on conscious-

R e p ro d u c e d with perm ission of the copyright owner. F urther reproduction prohibited without perm ission.

ness raising, self-help and alternative life styles.
For most American feminists the locus of women's oppression is
seen as rooted in biological inferiority arguments.

Feminists have

tried to settle the nature-nurture debate by showing that differen
tial socialization accounts for women's inferior status and not
biological differences.

In their attempt to overthrox* the dictim

"Biology is destiny", feminists have argued that menstrual cramps,
problems during pregnancy and childbirth, and menopausal symptoms
are largely culturally induced and do not warrant medical interven
tion.

American feminists often revert to micro-psychological explana

tions such as that male supreraists are afraid and envious of women's
reproductive and greater sexual capacity and thus invented the
menstrual and menopausal myths as forms of social control to keep
women in their subordinate role.
The feminist movement in Britain, as in most European countries,
is closely aligned with the socialist movement (Adam, 1977; Boxer &
Quetaert, Currell, 1974).

Marxist feminists contend that sexism and

women's oppression is an inherent function of capitalism, and thus
advocate a radical restructing of society along socialist lines (Fee,
1975).

Since the locus of women's oppression is seen as structur

ally located, it appears that the biological debate as a feminist is
sue has a lower priority for British women.
In both countries, clinical practice is largely discrepant with
research findings.

In the U.S. large numbers of women are still re

ceiving ERT for indefinite periods.

In Britain the relatively small

number of women who are on ERT are receiving it in a mode contradicto
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ry to research recommendations.

McKinley and McKinley (1973, p.

535) attribute practitioners’ dismissal of research findings, par
ticularly in regard to menopause, to their over-reliance on "clini
cal practice" and subjective experience, regardless of its lack of
objectivity and substantiation.
Medical sociologists also call attention to the conflict created
between the different segments of the medical community, as each
group tries to further its special interests (Freidson, 1971; Zola
& Miller, 1971).

A?

As Pfohl so aptly stated:

Although the medical profession often appears to
outsiders as a separate and unified community,
and although medical professionals generally favor
the maintenance of this image, it is nonetheless
more adequately described as an organization of
internally competing segments, each striving to
advance its own historically derived mission and
future importance (1977, p. 317).
Organizational and economic factors inherent in the different
health care systems probably explain much of the divergence in phy
sician practice between the two countries.

British medicine is

nationalized, whereas U.S. health care is in private hands.

In Brir

tain the GP is paid by the National Health Service on an annual capi
tation fee, which is fixed for each patient on his list, a rate not
affected by the frequency of patient visits.

The relatively low pay

and prestige associated with general practice has resulted in a se
vere shortage of GPs (Barnard & Lee, 1977; Forsyth, 1966).
The average British GP is overworked, which encourages work pat
terns that minimize patient contact.

Women on ERT need to be kept un

der close diagnostic surveillance and it is recommended that an endo
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metrial biopsy be performed every six months.

Since frequency of vis

it does not increase the GP's income, he might be more willing to
treat menopausal complaints with tranquilizers (as has frequently
been charged) to minimize contact.
the situation is different.

In the U.S., on the other hand,

Since the American physician operates on

a fee-for-service basis, frequent patient contact is economically re
warding and encourages what Freidson (1971) calls "medical imperia
lism."^
The doctor-patient interaction is also subtly influenced by the
structure of the health care system.

Freidson's (1975) comparison of

prepaid group practice to private entrepreneural practice provides a
useful insight to the effect of structure on physician and patient
roles.

Though his analysis is confined to the U.S., the structure of

prepaid-service-contract practice is analogous to Britain's National
Health Service and is thus relevant to our analysis.

According to

Freidson, private practice is conducive to a "merchant-customer" rela
tionship.

Like merchants, physicians are concerned with maintaining

or increasing their income and must "sell" the customer to buy their
service.

The pre-paid group service eliminates the fee and discour

ages the profit motive, while it sets up the physician as official
"gatekeeper" to service.

The patient is put in a "bureaucratic cli

ent" role— their rights and obligations specified in a formal con
tract.

In private practice the "customer" can shop around for de

sired service; but the "client" must get his or her service from the
pre-paid practice.

The contractual arrangement is conducive to the

emergence of an aggressive client demanding his or her right to ser-
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vice or medication.
The British GP, in his role as gatekeeper, constrained by a
tightly controlled budget, must prioritize the available resources.
Blomqvist (1979) has attributed the relatively low cost of health
services in the UK (relative to Canada and the U.S.) to the GP's
gatekeeper role.

He maintained that the GP is a powerful barrier to

any unnecessary service or medication.

44

Were the use of ERT to be

come widespread in Great Britain, physicians maintain that the cost
would tax the already tight NHS budget prohibitively (Evans, 1979).
British women, on the other hand, demand ERT:
...for under the National Health Act it is the
duty of the general practitioner to give
"reasonable and necessary care" to those on his
list. Who can deny that hormone replacement
therapy for those with signs of oestrogen de
ficiency symptoms is "reasonable and necessa
ry"? (Dalton, 1976, p. 77).
A somewhat different but complementary explanation is offered by
medical sociologist and historian Rosemary Stevens (1977, pp. 27-28).
In an historical analysis of the British and American health care
systems, she concluded that American medical care is linked with sel
ling technology, whereas British care has an "almost antitechnological bias."

Stevens also stated that British and American prac

titioners have different conceptions of health and illness.

British

family practice focuses on maintaining health and on the individual's
ability to cope with everyday working situations, whereas American
medicine is relatively more focused on diagnosing and treating ill
ness.

A result of this difference is that American physicians find

more illness and disease, while the British doctor tends to under
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diagnose (in American terms) and perhaps finds less disease.

The

British GP also spends relatively more time on depression and anx
iety states.

In a private communication, Stevens (1980) also hypo

thesized that the more conservative British GP is more concerned with
"feeling well" and the American practitioner, influenced by the
American youth culture, with "looking well".
It has often been charged that America is an overmedicated soci
ety (for example Illich, 1976; Lee, 1980).

The widespread use of ERT
45

might be an indication of this general trend.

Conrad and Schneider

(1980) also state that American society provides a fertile ground for
medicalization.

A variety of factors— such as the American medical

profession’s unparalleled power, the profit motive of a private system,
a strong heritage of experimentation and extraordinary faith in scien
tific and technological solutions, a fetish for the latest and the
best, and a strong penchant for pragmatic and individual rather than
structural solutions— contribute to excessive medicalization.
Finally the pharmaceutical industry has also played a role in
shaping the ERT controversy in both countries.
of this influence was on physician practice.

In the U.S. the locus
The work of Robert

Wilson was financed by drug companies and in the late 1960s the drug
industry launched a major promotional campaign for ERT in the medical
literature and lay press.

Immediately after the 1975 cancer studies,

Ayerst Laboratory hired the public relations firm of Hill and
Knowlton to counteract the negative publicity.

46

In Great Britain

there has been significant interaction between the pharmaceutical in
dustry and the research community.

Though the behavioral implications
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are not clear-cut, we should note that virtually all the osteoporosis
and sequential therapy research in Britain was partially or fully
funded by drug companies.

The one American study refuting the can

cer studies (Horwitz & Feinstein, 1979) was also funded by the phar
maceutical industry.

Theoretical Implications

If a sociological theory or perspective is to go beyond mere
philosophizing, it must help us gain a greater understanding of
specific social phenomena.

Thus we examine and assess the utility of

the positivist and social constructionist perspectives in helping us
understand the origins, dynamics and possible resolution of the ERT
Controversy.

Positivist Explanation

Positivists define social problems as objective conditions which
are detrimental to human well-being (Manis, 1976).

Thus ERT became

a social problem in the U.S. because scientific inquiry found it to
be harmful to women's health.

New knowledge about ERT and cancer pro

duced social strain— defined as a disharmony between objective condi
tions and normative standards (Smelser, 1962, p. 287)— which in turn
caused widespread discontent and social protest.

Strain, in short,

turned a latent problem into a manifest one.
Yet in Great Britain ERT is not defined as a social problem, not
at least in the same way as it is in the U.S.
British differences?

What accounts for the

ERT has not become a social problem in Great
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Britain, positivists would say, because the English have not ex
perienced the same rise in endometrial cancer rates; moreover, os
teoporosis, for which ERT might be an effective treatment, consti
tutes a serious health problem for British women.
The positivistic view of science holds that disputes are set
tled according to the scientific merits of arguments, and that adjudi
cation proceeds according to a logical, rigorous method.
American and British researchers still disagree?

Then why do

Obviously one side

must simply be in error, led temporarily astray by social and contex
tual factors.
There are several problems with these positivistic explanations.
First, health risk is not a consistent factor in determining what
conditions become social problems.
that alcohol and cigarettes

47

Scientific inquiry has determined

represent a serious health risk, yet

they are both legal, freely available drugs.

Environmental pollutants

and many industrial working conditions constitute a great threat to
the health and safety of millions of Americans, yet the current trend
is for deregulation.

On the other hand, scientific inquiry has been

unable to determine a convincing health risk associated with marijua
na use, yet it is defined as a social problem.
Second, that strain, in the form of cancer, gave rise to social
protest is also an inadequate explanation.

Feminists have historical

ly opposed medicine's definition and treatment of menopause.

Femi

nist opposition to ERT developed before the 1975 cancer studies.
so:

why were early cancer warnings, such as Gusberg's 1947 study,

ignored by the medical community and feminists alike?

Positivists
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must explain a 28-year lag between a scientific finding and its
emergence as strain.
Third, that osteoporosis constitutes a health problem of great
er dimensions than endometrial cancer for British women is probably
true.
U.S.

However, osteoporosis is also a major health problem in the
It is estimated that each year 195,000 hip fractures occur due

to thinning bones, resulting in 19,500

deaths and a total cost of

over one billion dollars (Gastel & Brody, 1979).

In contrast annual

deaths attributed to endometrial cancer, because of its high cure
rate, number only about 3300 (American Cancer Society, 1977).
Regarding differences among researchers, the absolutist posi
tion— that one side must be in error— is not particularly useful.
Accepted practice often seems in error when examined historically.
Since American and British researchers share a common data base, and
science is seen as universalistic, an error explanation does little
to help us understand the origins, dynamics and possible resolution
of the ERT controversy.

Social Constructionist Explanation

The social constructionist perspective is based on the assumption
that there is no such thing as a single "objective" definition of re
ality; there are various (often competing) realities, which are de
fined by different interest groups, publics, or cultures.

As Mauss

stated:
We are dealing here with various definitions not
only of social reality, but even of physical real
ity. The same empirical data, whether about society
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or about the universe, can be used to support a
variety of conceptions of reality; indeed, we
might say that a certain socially defined design,
organization, or meaning is simply imposed on
data or "facts" which otherwise have no meaning
in and of themselves.... So it is that even physi
cal or "scientific" reality can be socially
constructed and thus relative to a particular
people and particular time (1975, p. 4).
Objective conditions may have little or nothing to do with con
sensual reality.

Standards of health and illness are not fixed

scientific ones, but rather they entail judgments that vary along so
ciocultural lines (Schur, 1980).

Our historical analysis of the chang

ing definitions of menopause (see Chapter 2) shows that medical ex
planations of the menopause have always been profoundly influenced
by cultural views of women and aging.

Such historically located events

as the Industrial Revolution, the rise of Freudian ideas and the men
tal health movement, and the pharmaceutical revolution all have had an
impact on the medical profession’s perception of menopause.
In understanding the different positions taken by ERT partisans,
socio-historical alignment may be more important than "objective
facts."

Indeed we claim that the feminist-physician and the re-

searcher-physician disputes over ERT can be best understood in con
textual terms.
In both countries, the physician-feminist variance can be inter
preted as sexual politics.

The substantive nature of the dispute is

relatively unimportant (sociologically); what matters is the power
relationship between male physicians and female patients.

Women and

physicians are engaged in a struggle over competing definitions of
menopause.

Schur (1980) calls these struggles over collective defi-
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nitions "stigma contests".

Various subordinate groups in a given so

ciety who have been labeled deviant, be they homosexuals, former men
tal patients, the handicapped, minorities or women, increasingly or
ganize to counter such stigma.

Although economic, legal, and narrow

political power are often involved in stigma contests, "what is essen
tially at stake in such situations is the power of moral standing or
acceptability" (Schur, 1980, p. 6).

Thus stigma contests are always

partly symbolic in nature, since prestige and status are important
issues (see Gusfield, 1966, 1967).

Stigmatized individuals must rec

tify a "spoiled identity" (Goffman, 1963) through collective efforts.
As we have noted women in both countries try to counteract the stigma
of menopause.

In the U.S. feminists tried to neutralize the stigma by

claiming that menopause is normal; in Britain women claim that meno
pausal problems are "real" and not just in their heads.
The researcher-physician dispute can also be understood in terms
of cultural context.

Researchers* professional prestige, whether A-

merican or British, is increased if they have found a cause of cancer
qr a cure for osteoporosis.
mental criteria differ.

At the level of the practitioner, judg

For the American practitioner a disease label

is economically rewarding; no such advantage exists for the British
GP, indeed the label may be disadvantageous, in his gatekeeper role.
Social problems and deviance categories do not arise by them
selves, according to social constructionists, but are the result of
enterprise.

Becker (1963) has sensitized us to the role of moral en

trepreneur in the creation of collective definitions.

Both Robert

Wilson in the U.S. and Wendy Cooper in Great Britain filled this role
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of moral crusader and were instrumental in the promotion of the dis
ease label.
Similarly Mauss (1975) contends that social problems are the re
sult of social movements.

Conditions that become defined as social

problems often have existed for a very long time before they acquired
the label.

It takes the concerted efforts of interest groups to de

fine what constitutes a social problem.

Most of the conditions that

feminists decried have existed for a long time.

It was through the

collective actions of the women's health movement that gynecological
care became defined as a social problem.
Resource mobilization theory holds that the success or failure of
social protests depends largely on challengers' ability to organize and
mobilize resources.

In Britain the feminist opposition is still large

ly an individualized effort.

The relatively greater success of Ameri

can feminists can be attributed to greater organization.

The meno

pause issue is one of several health related issues under the umbrella
of the women's health movement.

As a national movement with access to

media and government, various women's health groups, in coalition with
several national consumer groups, have lobbied (with some success) for
policy changes about ERT.
In conclusion, the medical model, essentially a positivistic view
of science, does not adequately explain why two countries reached con
tradictory conclusions to the same problem, when the same scientific
data were available to both sides.

The social constructionist model,

attuned to cross-cultural richness and subtlety goes further in ex
plaining the development and dynamics of the Estrogen Replacement Con-
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troversy.
One can only speculate on the likely outcome of the controversy.
The positivist position would hold that the controversy will even
tually be resolved based on the scientific merits of the arguments.
It is our contention that social forces will continue to play a cen
tral role.

If the controversy is to be resolved at all, it will most

likely be settled by external social factors rather than purely in
ternal, scientific ones.
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FOOTNOTES

1

Though history is the focus of this chapter, my approach has
been as a sociologist, not an historian. My interest is in. background
and context rather than a compilation of detail. Thus I have made no
systematic investigation of primary materials, particularly of the
Victorian era. The best listing of primary sources for that period
-is found in The Surgeon General’s Catalogue. I made no attempt to lo
cate and read all materials listed under the heading of menopause.
Indeed no historian has done so and a history of the menopause has not
yet been written. We await the investigation of a feminist medical
historian to shed light on this subject.
For the Victorian era I relied mostly on fragments of work and
brief mentions of the menopause, mostly in the work of historians.
Where primary works were often cited or seemed crucial, I obtained
them from local collections or on loan. The later periods covered in
this chapter presented fewer problems. I read all important primary
sources, such as the work of Robert A. Wilson as well as a variety of
gynecological texts and books and articles published in medical jour
nals. My interpretation of these various sources was aided by a varie
ty of sociologists, psychologists and feminists.
The availability of sources has two important implications for
the scope of this chapter. First, we begin with the Victorian era,
rather than some earlier time, because contemporary scholarship has so
far ignored previous periods. Moreover, because of the interest of
historians, this section emphasized European materials. Second, and
in opposition to the previous point, for the 1960 to 1975 period, most
primary and secondary sources come from the United States. Thus the
chapter concludes by focusing on the American scene.
2 Since the eighteenth century, medical science has increasingly
assumed social control functions which previously have been the prero
gative of religion or the state. For a discussion of physicians as
agents of social control see Conrad and Schneider (1980), Ehrenreich
and Ehrenreich (1975); Freidson (1975); Haller and Haller (1974);
Ruzek (1978); Smith-Rosenberg and Rosenberg (1973); and Zola (1972).
3
Thorsten Veblen in The Theory of the Leisure Class (1908) pointed
to the burden placed on women to bring about order and stability to the
confused and transient social structure during the rise of indus
trialization. A wife was expected to stay home as a symbol of her
husband's earning power. Yet the middle-class woman, according to
Veblen, acted only as "ceremonial consumer". Her transformation from
producer of goods to consumer marked no advancement in her personal
freedom. "She still quite unmistakably remains his chattel in theory.

"■

—

— —

—
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For the habitual rendering of vicarious leisure and consumption is
the abiding mark of the unfree servant" (1980, pp. 81-83).

4

For an interesting discussion of gynecological surgery see
Barker-Benfield (1976). According to this historian, "female castra
tion" ("oophorectomy") was a widespread and frequently performed
operation for mental disorders, practiced from the mid-nineteenth
century to as late as 1946. "During the operation's heyday doctors
boasted that they removed from 1,500 to 2,000 ovaries a piece" re
ports Barker-Benfield (1976, pp. 120-121). Another common sexual
surgery performed on women for mental disorders and to check what was
thought to be a growing incidence of masturbation was clitoridectomy, the surgical removal of the clitoris. This procedure was first
performed in 1872 and continued until 1925.
^Women are more subject to institutionalization on specious
grounds than men, are treated more extensively with shock therapy and
mind
controlling drugs,and receive the majority of lobotomies, accor
ding to a study done byRoth and Lerner (1974).

6In diagnosing menopausal symptoms as largely psychological, the
gynecologist's function as the dominant labeler of female physiology
was extended to define female psychology as well. Weideger defines
the gynecologist's intrusion into a field where he has little training
as taking on the role of shaman:
The gynecologist has taken upon himself the role
of diviner. He assesses the quality of normal
behavior - normal not only in the biological sense
but in a social sense as well. By his own declara
tion he has specialized knowledge of a woman's
body, her real spiritual potential, and the true
nature of her unconscious as well (1976, p. 133).
In his role as witch doctor, the gynecologist uses
a medical school training but combines it, in a
peculiar mixture with a watered down version of
psychoanalytic theory (1976, p. 134)
Of course, this intrusion into a woman's psychological sphere by
gynecologists is not new, as the Victorian era has shown.
For example, the author stated that 86 of the 304 women had un
dergone a total hysterectomy either before or during treatment with
out giving a reason for the hysterectomy.

8
As late as the 1960s, a White House physician publicly stated
that women were unsuited for high governmental office and could never
be President because of their "raging hormones" (quoted in Frieze,
et al., 1978).
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9

The data for this section are the various journal articles,
editorials, and conference reports written by medical researchers, as
well as various published interviews with key scientists. Our pur
pose is to treat these reports as indicators of medical opinion, and
as measures of consensus or discensus. Thus we make no attempt to
assess the medical validity of these researches. Rather we treat
them naturalistically— as claims-making activities. This approach
to data applies to all groups and claims discussed in this chapter.
One stylistic note: where American and British spelling or ter
minology differ, we use American notation except in direct quotation
of British material. Thus the British "oestrogen" is rendered
American style; "flushes" become "flashes", and Hormone Replacement
Therapy is written as Estrogen Replacement Therapy.
^ S e e Gray et al., 1977; Hoogerland et al., 1978; Horwitz et al.,
1978; Mack et al., 1976; McDonald et al., 1977; Smith et al., 1975;
Ziel et al., 1975; Ziel et al, 1976 as interpreted by Antunes et al.,
1979; Hammond et al., 1979; Hutchinson et al., 1978; and Jick et al.,
1979.
■^One study criticized the previous cancer research on methodo
logical grounds. Among the criticisms were that women come under
greater diagnostic surveillance from their physicians so that cancer
is more likely to be found. Moreover most epidemiological studies
use historical controls; that is, they compare current cases of
cancer with controls matched on a post-hoc basis, leading to a
possible over-estimation of the cancer risk. Mis classification of
endometrial hyperplastic lesions as early endometrial carcinoma has
also been charged (Horwitz & Feinstein, 1978). This work was par
tially funded by Ayerst Laboratories.
12
A fourth editorial, written in May of 1979, acknowledged the
cancer link. This editorial drew several angry responses from re
searchers.
■^See Paterson et al., 1980; Sturdee et al., 1978; Thom et al.,
1979; Whitehead et al., 1977. These studies were all partially or
totally funded by the pharmaceutical industry.
14

See Horsman et al., 1977; Lindsay et al., 1976; Lindsay et al.,
1978; Nordin et al., 1980. Again, these studies were all partially or
totally funded by the pharmaceutical industry.
15
Since there are no data on physician-patient interaction con
cerning the ERT decision, all of our measures of physician behavior
are necessarily indirect. In this section, therefore, we relied on
various survey data, authoritative medical references, various
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medical writings, statements made by physicians' professional or
ganizations, and marketing data. Marketing data are published by
International Medical Statistics (IMS), and consists of surveys
of physician practices and prescription counts.
16
A 1975 article in JAMA estimated that 86 percent of all women
use a gynecologist as their principal physician (Pearson, 1975)
and the AMA recently proposed to have obstetrician/gynecologists for
mally recognized as women's primary health providers (cited in Ruzek,
1978).
■^This statement drew an angry response from feminists. Gross
man and Bart (1978, p. 182) state: "A symptom is an outward sign of
an underlying problem. That this physician chooses to give car
cinogens to women to deal with problems they are not experiencing is
the ultimate in medical arrogance and represents medicine's attempt
to take over not only our bodies but even our sense of reality".
18

These statistics are taken from the IMS National Disease and
Therapeutics Index. "Data are obtained from a representative panel
of physicians who report case history information on private patients
seen over a given period of time. Over fifteen hundred physicians
report four times a year on a 48-hour period of their practice....
The basic information document for this study is the physician's case
report of each patient contact, whether it occurred in the physician's
office, in the hospital, in the patient's home, via telephone, etc."
(IMS, 1981).
19

Sidney Wolfe testified at a FDA hearing that in 1978, 75,000
progestin and 5000 DES prescriptions were written for pregnant women
(although physician inserts clearly state that estrogens and progestins should not be given to pregnant women since they may seriously
injure the fetus) and 194,000 to suppress lactation— a practice for
which there is no evidence of effectiveness (Wolfe, 1979).

20

The New England Journal of Medicine has consistently warned
of the cancer risks associated with estrogen use, and in 1978 edito
rially denounced the Horwitz and Feinstein (1978) study which ques
tioned the validity of the previous cancer studies.

21
The consultants based at teaching and research hospitals hold
highly prestigious salaried posts, and all other physicians are ex
cluded from hospital practice. They also have the option of re
taining a private practice outside the hospital (Sidel & Sidel, 1977).
22

A London Times article (Gillie, 1978) charged that Women's
Health Care was financed by Ayerst Laboratory and served as a front
for PR activities.
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23

The data for this section are a wide variety of books, articles,
organizational newsletters and brochures written and prepared by
feminist, health and consumer groups* Additional material comes from
court testimony and affadavits prepared for court cases and FDA hear
ings relating to ERT.
^ W e thank Professor David Edge of Edinburgh University for bring
ing this group to our attention.

25
In addition to various secondary sources, data for this section
come from government documents, correspondence and interviews, and
from affadavits, court testimony and judge’s opinions in Federal court
cases.
26

At about the same time, Ayerst Laboratory (the manufacturer
of the most widely used ERT product, Premarin) sent a reassuring "Dear
Doctor" letter to all physicians. The letter did not refer to the
recently published cancer studies but recommended "business as usual."
Alexander Schmidt, then FDA Commissioner, called this act "ir
responsible" (Lieberman, 1977).
27

The other three are oral contraceptives, progestational drug
products, and isoproterenal inhalation preparations used by asthmatics.

28

Since the regulation was first promulgated, the FDA has proposed
changes which relax the dispensing requirements for incompetents and
eliminate them for men (Stapleton, 1980).
29
It is likely that this figure would even be lower if physician
practices were surveyed.
30
Only after considerable public furor over the thalidomide
disaster was this Committee formed. Originally it was known as the
Committee on the Safety of Drugs (or informally as the Dunlop Com
mittee, named after its first chair), but under the Medicines Act of
1968 was renamed as the CSM.
31
Products already on the market in September of 1971 (about
36,000) were given product Licenses of Right, products which never
had undergone independent evaluation. To review these drugs, the
Committee on Review of Medicines (CRM) was created in 1975 and given
a 1990 deadline to complete this task. This Committee operates very
much like the CSM— its members are appointed by the health ministers
and also represent physicians, scientists and drug manufacturers.
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32

In contrast to the FDA, an agency which rules on both effecacy and safety, the CSM is mainly concerned with safety. In fur
ther contrast to the FDA, the CSM’s decisions are not final. The
Committee only advises the Licensing Authority, which is part of the
Medicines Division of the Department of Health and Social Security
(DHSS). Manufacturers may appeal an adverse decision of the Licens
ing Authority, taken on the advice of the CSM, to the Medicines Com
mission. This 14 member committee is again composed of scientists,
physicians, pharmacists, veterinarians, and representatives of the
pharmaceutical industry. These members are appointed by the Minis
ters after consulting with interested organizations, and serve in a
part-time virtually honorary capacity (Binns, 1980; Dunlop, 1973).
33
We have not been able to get primary documentation of this CSM
statement, and members of the CSM and the Medicines Division of the
DHSS have denied our requests for interviews. Considering the in
formal structure of the CSM, it is possible that no such documenta
tion exists. As Sir Derrick Dunlop, the first chair of the Com
mittee stated, "much of the Committee’s contact with the applicants
took place in robust but usually good-humored encounters over the
telephone or in informal meetings rather than in official communi
cations duplicated for the record" (1973, p. 232).
The senior principal medical officer of the Medicines Division
stated in a letter that the CSM has not issued any "public releases"
on ERT but that the Committee was "concerned that literature related
to unopposed oestrogen preparations [promotional literature to medi
cal practitioners] should contain the warning that prolonged un
opposed oestrogen therapy may increase the risk of development of
endometrial carcinoma" (Griffin, 1980). (Emphasis added)
34
One explanation for this might be what a former NCI official
facetiously called the NIH (Not Invested Here) Syndrome. With as much
insight as humor, Schneiderman (1980) wrote us: "if we did not in
vent it here, how could it possibly be true?"
35
One purpose of the N1IS menopausal clinics is to carry out such
randomized controlled trials.

qg

As evidence Sontag cites the use of cancer as a metaphor to
depict various kinds of evil. Slums and pornography shops are depic
ted as "cancers" in our cities, communism as "cancer in our midst,"
and the Nixon administration as a cancer, rotten from within.
37
This anomolie has been puzzling to scholars (for example
Kessel, 1973). Even Sir Derrick Dunlop, first chairperson of the
CSM, stated: "it is...surprising that in the United States, the home
of big business and enterprise, the control of medicines should be

i
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more bureaucratically rigid than in the United Kingdom with its socalled socialized medicine" (1973, p. 237).
OQ

That the scientist and physician depend on the companies that
manufacture the drug for their income did not seem to disturb Sir
Derrick.
39

These feminists have recently been accused of a subtle ageism
and of denying their own hormones (Posner, 1980).
^ W e thank Rosamond Robbert for this insight. The same sort of
thinking is also implicit in the writings of Cooper (1975) and Evans
(1979).
^Although most American feminists come from a middle-class back
ground, they have not pursued any particular "class" interest in
Marxist terms.
^ T h e conflict created by the status and income disparity between
the British GP and the hospital based consultant has been amply do
cumented (Barnard et al., 1977; Forsyth, 1966; Mechanic, 1972; Sidel
& Sidel, 1973; Wallace, 1975).
1 Q

Much has been written about the extent of unnecessary surgery
performed by American physicians. For example the rate of hysterec
tomies in the U.S. is more than twice the rate in Britain (Bunker,
1970).
^ A comparison of drug consumption revealed that in the U.S. the
rate per 1000 population for prescription drugs was 344, whereas in
Great Britain it was only 247. This was the reverse for non
prescription, over-the-counter drugs with a rate of 9 for the U.S.
and 14 for Great Britain (Lee, 1980).
^ A World Health Organization survey found that in a comparison
of seven countries, the U.S. ranked first in the consumption of pres
cription drugs (Lee, 1980).
In December of 1976 a Hill and Knowlton vice president wrote a
letter to Ayerst outlining a promotional campaign "to protect and en
hance the identity of estrogen replacement therapy." This letter was
intercepted by an employee and turned over to a feminist newspaper,
Majority Report, which published the letter (Lieberman, 1977).
/7

In recent years there has been a reemergence of interest group
activities trying to define cigarette smoking as deviant behavior
(Markle & Troyer, 1979).
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